Cancer genes sorted by chromosome.
This table is a summary of the working cancer gene list. The full version of this table can be downloaded here .This is part of Table 1 in Futreal et al.
| Symbol | Name | Entrez GeneID | Chr | Chr Band | Mutation Type | Synonyms |
|---|---|---|---|---|---|---|
| ABL1 | v-abl Abelson murine leukemia viral oncogene homolog 1 | 25 | 9 | 9q34.1 | T, Mis | 25, ABL, ABL1, ENSG00000097007, JTK7, P00519, bcr/abl, c-ABL, p150, v-abl |
| ABL2 | v-abl Abelson murine leukemia viral oncogene homolog 2 | 27 | 1 | 1q24-q25 | T | 27, ABL2, ABLL, ARG, ENSG00000143322, P42684, RP11-177A2_3 |
| ACSL3 | acyl-CoA synthetase long-chain family member 3 | 2181 | 2 | 2q36 | T | 2181, ACS3, ACSL3, ASPM, CCDS2455.1, ENSG00000123983, FACL3, O95573, PRO2194, Q6PIM8 |
| AF15Q14 | AF15q14 protein | 57082 | 15 | 15q14 | T | 57082, AF15Q14, CASC5, D40, ENSG00000137812, Q8NG31 |
| AF1Q | ALL1-fused gene from chromosome 1q | 10962 | 1 | 1q21 | T | 10962, AF1Q, CCDS982.1, ENSG00000213190, MLLT11, Q13015, Q6FGF7 |
| AF3p21 | SH3 protein interacting with Nck, 90 kDa (ALL1 fused gene from 3p21) | 51517 | 3 | 3p21 | T | 51517, AF3P21, AF3p21, CCDS2776.1, ENSG00000213672, NCKIPSD, ORF1, Q6GU34, Q8TC10, Q9NZQ3, SPIN90, WASLBP, WISH |
| AF5q31 | ALL1 fused gene from 5q31 | 27125 | 5 | 5q31 | T | 27125, AF5Q31, AF5q31, AFF4, CCDS4164.1, ENSG00000072364, MCEF, Q9UHB7 |
| AKAP9 | A kinase (PRKA) anchor protein (yotiao) 9 | 10142 | 7 | 7q21-q22 | T | 10142, AKAP350, AKAP450, AKAP9, AKAP9_ENST00000356239, AKAP9_NM_005751, B3KQF9, CCDS5622, CG-NAP, ENSG00000127914, HYPERION, KIAA0803, MU-RMS-40_16A, PRKA9, Q5GIA7, Q8IW64, Q99996, YOTIAO |
| AKT1 | v-akt murine thymoma viral oncogene homolog 1 | 207 | 14 | 14q32.32 | Mis | 207, AKT, AKT1, AKT1_NEW, B0LPE5, B2RAM5, B3KVH4, B3KXD7, B7Z5R1, CCDS9994, ENSG00000142208, MGC99656, P31749, PKB, PKB-ALPHA, PRKBA, Q9BV07, RAC, RAC-ALPHA |
| AKT2 | v-akt murine thymoma viral oncogene homolog 2 | 208 | 19 | 19q13.1-q13.2 | A | 208, AKT2, CCDS12552.1, ENSG00000105221, P31751, PKBBETA, PRKBB, RAC-BETA |
| ALDH2 | aldehyde dehydrogenase 2 family (mitochondrial) | 217 | 12 | 12q24.2 | T | 217, ALDH-E2, ALDH2, ALDHI, ALDM, CCDS9155.1, ENSG00000111275, MGC1806, P05091, Q53FB6, Q9UN17 |
| ALK | anaplastic lymphoma kinase (Ki-1) | 238 | 2 | 2p23 | T, Mis, A | 238, ALK, CD246, ENSG00000171094, Q9UM73, TFG/ALK |
| ALO17 | KIAA1618 protein | 57714 | 17 | 17q25.3 | T | 57674, ALO17, C17orf27, CCDS32761.1, ENSG00000173821, KIAA1554, Q63HN8, Q6ZSK6, RNF213 |
| APC | adenomatous polyposis of the colon gene | 324 | 5 | 5q21 | D, Mis, N, F, S | 324, APC, CCDS4107.1, DP2, DP2_5, DP3, ENSG00000134982, FAP, FPC, GS, P25054 |
| ARHGEF12 | RHO guanine nucleotide exchange factor (GEF) 12 (LARG) | 23365 | 11 | 11q23.3 | T | 23365, ARHGEF12, DKFZp686O2372, ENSG00000196914, KIAA0382, LARG, PRO2792, Q6P526, Q9NZN5 |
| ARHH | RAS homolog gene family, member H (TTF) | 399 | 4 | 4p13 | T | 399, ARHH, CCDS3458.1, ENSG00000168421, RHOH, RhoH, TTF |
| ARID1A | AT rich interactive domain 1A (SWI-like) | 8289 | 1 | 1p35.3 | Mis, N, F, S, D | 8289, ARID1A, B120, BAF250, BAF250a, BM029, C1orf4, ENSG00000117713, P270, RP1-50O24_1, SMARCF1 |
| ARID2 | AT rich interactive domain 2 | 196528 | 12 | 12q12 | N, S, F | 196528, ARID2, BAF200, CCDS31783.1, DKFZp686G052, DKFZp779P0222, ENSG00000189079, FLJ30619, KIAA1557, Q15KG9, Q4G0S8, Q68CP9, Q8NBP1, Q8WV72, Q96DQ8, Q96SQ4, p200 |
| ARNT | aryl hydrocarbon receptor nuclear translocator | 405 | 1 | 1q21 | T | 405, ARNT, CCDS970.1, ENSG00000143437, HIF-1beta, HIF1B, HIF1BETA, O43392, P27540, Q53F30, Q59ED4, Q5QP39, Q6P9C1, TANGO |
| ASPSCR1 | alveolar soft part sarcoma chromosome region, candidate 1 | 79058 | 17 | 17q25 | T | 79058, ASPSCR1, CCDS11796.1, ENSG00000169696, Q9BZE9 |
| ASXL1 | additional sex combs like 1 | 171023 | 20 | 20q11.1 | F, N, Mis | 171023, ASXL1, CCDS13201.1, ENSG00000171456, KIAA0978, MGC117280, MGC71111, Q498B9, Q6P1M8, Q8IXJ9 |
| ATF1 | activating transcription factor 1 | 466 | 12 | 12q13 | T | 466, ATF1, CCDS8803.1, ENSG00000123268, P18846, TREB36 |
| ATIC | 5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase | 471 | 2 | 2q35 | T | 471, AICARFT, ATIC, CCDS2398.1, ENSG00000138363, IMPCHASE, P31939, PURH, Q53S28 |
| ATM | ataxia telangiectasia mutated | 472 | 11 | 11q22.3 | D, Mis, N, F, S | 472, AT1, ATA, ATC, ATD, ATDC, ATE, ATM, DKFZp781A0353, ENSG00000149311, MGC74674, Q13315, TEL1, TELO1 |
| ATRX | alpha thalassemia/mental retardation syndrome X-linked | 546 | X | Xq21.1 | Mis, F, N | 546, A4LAA3, A8MTN6, ATR2, ATRX, ATRX_ENST00000373344, B4DHH8, B4DLE1, B4DLW1, B7Z1D8, CCDS14434, D3DTE2, MGC2094, MRXHF1, P46100, Q86U63, RAD54, RAD54L, SFM1, SHS, XH2, XNP, ZNF-HX |
| BAP1 | BRCA1 associated protein-1 (ubiquitin carboxy-terminal hydrolase) | 8314 | 3 | 3p21.31-p21.2 | N, Mis, F, S, O | 8314, BAP1, CCDS2853.1, DKFZp686N04275, ENSG00000163930, FLJ35406, FLJ37180, HUCEP-13, KIAA0272, Q92560, hucep-6 |
| BCL10 | B-cell CLL/lymphoma 10 | 8915 | 1 | 1p22 | T | 8915, BCL10, CARMEN, CCDS704.1, CIPER, CLAP, ENSG00000142867, c-E10, mE10 |
| BCL11A | B-cell CLL/lymphoma 11A | 53335 | 2 | 2p13 | T | 53335, BCL11A, BCL11A-L, BCL11A-S, BCL11A-XL, CCDS1862.1, CTIP1, ENSG00000119866, EVI9, FLJ10173, FLJ34997, KIAA1809, Q53TE8, Q53TS1, Q9H165 |
| BCL11B | B-cell CLL/lymphoma 11B (CTIP2) | 64919 | 14 | 14q32.1 | T | 64919, BCL11B, CCDS9950.1, CTIP-2, CTIP2, ENSG00000127152, Q9C0K0, RIT1, hRIT1-alpha |
| BCL2 | B-cell CLL/lymphoma 2 | 596 | 18 | 18q21.3 | T | 596, BCL2, Bcl-2, CCDS11981.1, ENSG00000171791 |
| BCL3 | B-cell CLL/lymphoma 3 | 602 | 19 | 19q13 | T | 602, BCL3, BCL4, CCDS12642.1, D19S37, ENSG00000069399, P20749 |
| BCL5 | B-cell CLL/lymphoma 5 | 603 | 17 | 17q22 | T | |
| BCL6 | B-cell CLL/lymphoma 6 | 604 | 3 | 3q27 | T, Mis | 604, BCL5, BCL6, BCL6A, CCDS3289.1, ENSG00000113916, LAZ3, P41182, ZBTB27, ZNF51 |
| BCL7A | B-cell CLL/lymphoma 7A | 605 | 12 | 12q24.1 | T | 605, BCL7, BCL7A, ENSG00000110987 |
| BCL9 | B-cell CLL/lymphoma 9 | 607 | 1 | 1q21 | T | 607, BCL9, ENSG00000116128, LGS, MGC131591 |
| BCOR | BCL6 corepressor | 54880 | X | Xp11.4 | F, N, S, T | 54880, ANOP2, BCOR, CCDS14250.1, ENSG00000183337, FLJ20285, FLJ38041, KIAA1575, MAA2, MCOPS2, MGC131961, MGC71031 |
| BCR | breakpoint cluster region | 613 | 22 | 22q11.21 | T | 613, ALL, BCR, BCR1, CCDS13806.1, CML, D22S11, D22S662, ENSG00000186716, FLJ16453, P11274, PHL |
| BHD | folliculin, Birt-Hogg-Dube syndrome | 201163 | 17 | 17p11.2 | Mis. N, F | 201163, BHD, ENSG00000154803, FLCL, FLCN, MGC17998, MGC23445 |
| BIRC3 | baculoviral IAP repeat-containing 3 | 330 | 11 | 11q22-q23 | T | 330, AIP1, API2, BIRC3, CCDS8315.1, CIAP2, ENSG00000023445, HAIP1, HIAP1, MALT2, MIHC, Q13489, RNF49, cIAP2, hiap-1 |
| BLM | Bloom Syndrome | 641 | 15 | 15q26.1 | Mis, N, F | 641, BLM, BS, CCDS10363.1, ENSG00000197299, MGC126616, MGC131618, MGC131620, RECQ2, RECQL2, RECQL3 |
| BMPR1A | bone morphogenetic protein receptor, type IA | 657 | 10 | 10q22.3 | Mis, N, F | 657, ACVRLK3, ALK3, BMPR1A, CCDS7378.1, CD292, ENSG00000107779, P36894 |
| BRAF | v-raf murine sarcoma viral oncogene homolog B1 | 673 | 7 | 7q34 | Mis, T, O | 673, B-raf 1, B-raf1, BRAF, BRAF1, CCDS5863.1, ENSG00000157764, MGC126806, MGC138284, P15056, RAFB1 |
| BRCA1 | familial breast/ovarian cancer gene 1 | 672 | 17 | 17q21 | D, Mis, N, F, S | 672, BRCA1, BRCAI, BRCC1, ENSG00000012048, IRIS, PSCP, RNF53 |
| BRCA2 | familial breast/ovarian cancer gene 2 | 675 | 13 | 13q12 | D, Mis, N, F, S | 675, BRCA2, BRCC2, ENSG00000139618, FACD, FAD, FAD1, FANCB, FANCD, FANCD1, RP11-298P3_4 |
| BRD3 | bromodomain containing 3 | 8019 | 9 | 9q34 | T | 8019, BRD3, ENSG00000169925, KIAA0043, ORFX, Q15059, RING3L |
| BRD4 | bromodomain containing 4 | 23476 | 19 | 19p13.1 | T | 23476, BRD4, BRD4_ENST00000263377, CAP, CCDS12328, ENSG00000141867, HUNK1, HUNKI, MCAP, O60885, Q05BM2, Q5BJ26, Q6NXE4, Q6PIS5, Q96HN0 |
| BRIP1 | BRCA1 interacting protein C-terminal helicase 1 | 83990 | 17 | 17q22 | F, N, Mis | 83990, BACH1, BRIP1, CCDS11631.1, ENSG00000136492, FANCJ, FLJ90232, MGC126521, MGC126523, OF, Q9BX63 |
| BTG1 | B-cell translocation gene 1, anti-proliferative | 694 | 12 | 12q22 | T | 694, BTG1, CCDS9043.1, ENSG00000133639, P62324, Q6IBC8 |
| BUB1B | BUB1 budding uninhibited by benzimidazoles 1 homolog beta (yeast) | 701 | 15 | 15q15 | Mis, N, F, S | 701, BUB1B, BUB1beta, BUBR1, Bub1A, CCDS10053.1, ENSG00000156970, MAD3L, O60566, SSK1, hBUBR1 |
| C12orf9 | chromosome 12 open reading frame 9 | 93669 | 12 | 12q14.3 | T | |
| C15orf21 | chromosome 15 open reading frame 21 | 283651 | 15 | 15q21.1 | T | |
| C15orf55 | chromosome 15 open reading frame 55 | 256646 | 15 | 15q14 | T | 256646, C15orf55, CCDS32190.1, ENSG00000184507, NUT, Q86Y26, Q86YS8, Q9NTB3 |
| C16orf75 | chromosome 16 open reading frame 75 | 116028 | 16 | 16p13.13 | T | 116028, C16orf75, CCDS10548.1, ENSG00000175643, MGC24665, Q96E14, RMI2 |
| C2orf44 | chromosome 2 open reading frame 44 | 80304 | 2 | 2p23.3 | T | 80304, C2orf44, CCDS1705.1, ENSG00000163026, FLJ21945, PP384, Q8IYK0, Q9H6R7, Q9HBP5 |
| CAMTA1 | calmodulin binding transcription activator 1 | 611501 | 1 | 1p36.31-p36.23 | T | 23261, CAMTA1, CCDS30576.1, ENSG00000171735, KIAA0833, Q7Z7P1, Q96S92, Q9Y6Y1 |
| CANT1 | calcium activated nucleotidase 1 | 124583 | 17 | 17q25 | T | 124583, CANT1, CCDS11760.1, ENSG00000171302, Q8WVQ1, SCAN-1, SHAPY |
| CARD11 | caspase recruitment domain family, member 11 | 84433 | 7 | 7p22 | Mis | 84433, BIMP3, CARD11, CARMA1, CCDS5336.1, ENSG00000198286, MGC133069, Q9BXL7 |
| CARS | cysteinyl-tRNA synthetase | 833 | 11 | 11p15.5 | T | 833, CARS, CCDS7742.1, ENSG00000110619, P49589, Q53HG6 |
| CBFA2T1 | core-binding factor, runt domain, alpha subunit 2;translocated to, 1 (ETO) | 862 | 8 | 8q22 | T | 862, CBFA2T1, CCDS6257.1, ENSG00000079102, Q7Z4J5, Q9HBV9, RUNX1T1 |
| CBFA2T3 | core-binding factor, runt domain, alpha subunit 2; translocated to, 3 (MTG-16) | 863 | 16 | 16q24 | T | 863, CBFA2T3, CCDS10972.1, ENSG00000129993, ETO2, MTG16, MTGR2, O60615, O60616, O60617, O75081, Q0P5Z6, ZMYND4 |
| CBFB | core-binding factor, beta subunit | 865 | 16 | 16q22 | T | 865, CBFB, CCDS10827.1, ENSG00000067955, PEBP2B, Q13951, Q9HCT2 |
| CBL | Cas-Br-M (murine) ecotropic retroviral transforming | 867 | 11 | 11q23.3 | T, Mis S, O | 867, C-CBL, CBL, CBL2, CCDS8418.1, ENSG00000110395, RNF55 |
| CBLB | Cas-Br-M (murine) ecotropic retroviral transforming sequence b | 868 | 3 | 3q13.11 | Mis S | 868, CBLB, CCDS2948.1, DKFZp686J10223, DKFZp779A0729, DKFZp779F1443, ENSG00000114423, FLJ36865, FLJ41152, Nbla00127, RNF56 |
| CBLC | Cas-Br-M (murine) ecotropic retroviral transforming sequence c | 23624 | 19 | 19q13.2 | M | 23624, CBL-3, CBL-SL, CBLC, CCDS12643.1, ENSG00000142273, Q9ULV8, RNF57 |
| CCDC6 | coiled-coil domain containing 6 | 8030 | 10 | 10q21 | T | 8030, CCDC6, CCDS7257.1, D10S170, ENSG00000108091, H4, PTC, Q05CP8, Q16204, Q6GSG7, TPC, TST1 |
| CCNB1IP1 | cyclin B1 interacting protein 1, E3 ubiquitin protein ligase | 57820 | 14 | 14q11.2 | T | 57820, C14orf18, CCDS9547.1, CCNB1IP1, ENSG00000100814, HEI10, Q9NPC3 |
| CCND1 | cyclin D1 | 595 | 11 | 11q13 | T | 595, BCL1, CCDS8191.1, CCND1, D11S287E, ENSG00000110092, PRAD1, U21B31 |
| CCND2 | cyclin D2 | 894 | 12 | 12p13 | T | 894, CCDS8524.1, CCND2, ENSG00000118971, KIAK0002, MGC102758, P30279, Q53ER2 |
| CCND3 | cyclin D3 | 896 | 6 | 6p21 | T | 896, CCDS4863.1, CCND3, ENSG00000112576, P30281, Q6FG62 |
| CCNE1 | cyclin E1 | 898 | 19 | 19q12 | A | 898, CCDS12419.1, CCNE, CCNE1, ENSG00000105173, P24864 |
| CD273 | programmed cell death 1 ligand 2 | 80380 | 9 | 9p24.2 | T | 80380, B7DC, Btdc, CCDS6465.1, CD273, ENSG00000197646, MGC142238, MGC142240, PD-L2, PDCD1L2, PDCD1LG2, PDL2, Q2LC89, Q9BQ51, bA574F11_2 |
| CD274 | CD274 molecule | 29126 | 9 | 9p24 | T | 29126, B7-H, B7H1, CCDS6464.1, CD274, ENSG00000120217, MGC142294, MGC142296, PD-L1, PDCD1L1, PDCD1LG1, PDL1, Q0GN75, Q9NZQ7 |
| CD74 | CD74 molecule, major histocompatibility complex, class II invariant chain | 972 | 5 | 5q32 | T | 972, CCDS34276.1, CD74, DHLAG, ENSG00000019582, HLADG, Ia-GAMMA, O19685, Q8SNA0, Q9TNQ4, Q9TNQ6, protein 41 |
| CD79A | CD79a molecule, immunoglobulin-associated alpha | 973 | 19 | 19q13.2 | O, S | 973, CCDS12589.1, CD79A, ENSG00000105369, IGA, MB-1, P11912, Q53FB8 |
| CD79B | CD79b molecule, immunoglobulin-associated beta | 974 | 17 | 17q23 | Mis, O | 974, B29, CCDS11655.1, CD79B, ENSG00000007312, IGB, P40259 |
| CDH1 | cadherin 1, type 1, E-cadherin (epithelial) (ECAD) | 999 | 16 | 16q22.1 | Mis, N, F, S | 999, Arc-1, CCDS10869.1, CD324, CDH1, CDHE, ECAD, ENSG00000039068, LCAM, P12830, UVO, uvomorulin |
| CDH11 | cadherin 11, type 2, OB-cadherin (osteoblast) | 1009 | 16 | 16q22.1 | T | 1009, CAD11, CCDS10803.1, CDH11, ENSG00000140937, OB, P55287, Q59EQ1, Q96CZ9 |
| CDK12 | cyclin-dependent kinase 12 | 51755 | 17 | 17q12 | Mis, N, F | 51755, CCDS11337.1, CDK12, CRK7, CRKR, CRKRS, ENSG00000167258, KIAA0904, Q9NYV4 |
| CDK4 | cyclin-dependent kinase 4 | 1019 | 12 | 12q14 | Mis | 1019, CCDS8953.1, CDK4, CMM3, ENSG00000135446, MGC14458, P11802, PSK-J3 |
| CDK6 | cyclin-dependent kinase 6 | 1021 | 7 | 7q21-q22 | T | 1021, CCDS5628.1, CDK6, ENSG00000105810, MGC59692, PLSTIRE, Q00534 |
| CDKN2A | cyclin-dependent kinase inhibitor 2A (p16(INK4a)) gene | 1029 | 9 | 9p21 | D, Mis, N, F, S | 1029, ARF, CDK4I, CDKN2, CDKN2A, CMM2, ENSG00000147889, INK4, INK4a, MLM, MTS1, P42771, TP16, p14, p14ARF, p16, p16INK4, p16INK4a, p19 |
| CDKN2C | cyclin-dependent kinase inhibitor 2C (p18, inhibits CDK4) | 1031 | 1 | 1p32 | D | 1031, CCDS555.1, CDKN2C, ENSG00000123080, INK4C, P42773, Q6ICV4, Q9P1T2, p18, p18-INK4C |
| CDKN2a(p14) | cyclin-dependent kinase inhibitor 2A-- p14ARF protein | 1029 | 9 | 9p21 | D, S | 1029, ARF, CCDS6511, CDK4I, CDKN2, CDKN2a(p14), CMM2, ENSG00000147889, INK4, INK4a, MLM, MTS1, Q5ZEY9, Q8N726, TP16, p14, p14ARF, p16, p16INK4, p16INK4a, p19 |
| CDX2 | caudal type homeo box transcription factor 2 | 1045 | 13 | 13q12.3 | T | 1045, CCDS9328.1, CDX2, CDX3, ENSG00000165556, Q5VTU7, Q99626, Q9UD92 |
| CEBPA | CCAAT/enhancer binding protein (C/EBP), alpha | 1050 | 19 | 19q13.1 | Mis, N, F | 1050, C/EBP-alpha, CEBP, CEBPA, P49715 |
| CEP1 | centrosomal protein 1 | 11064 | 9 | 9q33 | T | 11064, A2A2Y1, CCDS35118.1, CEP1, CEP110, CNTRL, ENSG00000119397, Q3MN79, Q5FWF8, Q5JVD0, Q5JVD1, Q5JVD6, Q6PKC1, Q7Z7A1, Q8TEP3, Q9Y489 |
| CHCHD7 | coiled-coil-helix-coiled-coil-helix domain containing 7 | 79145 | 8 | 8q11.2 | T | 79145, CCDS34896.1, CHCHD7, ENSG00000170791, FLJ40966, MGC2217, Q9BUK0 |
| CHEK2 | CHK2 checkpoint homolog (S. pombe) | 11200 | 22 | 22q12.1 | F | 11200, CCDS13843.1, CDS1, CHEK2, CHK2, ENSG00000183765, HuCds1, LFS2, O96017, PP1425, RAD53, RP11-436C9_1, bA444G7 |
| CHIC2 | cysteine-rich hydrophobic domain 2 | 26511 | 4 | 4q11-q12 | T | 26511, BTL, CCDS3493.1, CHIC2, Q9UKJ5 |
| CHN1 | chimerin (chimaerin) 1 | 1123 | 2 | 2q31-q32.1 | T | 1123, ARHGAP2, CHN, CHN1, ENSG00000128656, RHOGAP2, RhoGAP2, n-chimerin |
| CIC | capicua homolog | 23152 | 19 | 19q13.2 | Mis, F, S | 23152, CCDS12601.1, CIC, ENSG00000079432, KIAA0306, Q96RK0 |
| CIITA | class II, major histocompatibility complex, transactivator | 4261 | 16 | 16p13 | T | 4261, A0N0N9, C2TA, CCDS10544.1, CIITA, ENSG00000179583, MHC2TA, P33076, Q29704, Q66X48, Q8SNB7, Q96KL4 |
| CLTC | clathrin, heavy polypeptide (Hc) | 1213 | 17 | 17q11-qter | T | 1213, CCDS32696.1, CLTC, CLTCL2, ENSG00000141367, Q00610, Q49AL0 |
| CLTCL1 | clathrin, heavy polypeptide-like 1 | 8218 | 22 | 22q11.21 | T | 8218, CLTCL, CLTCL1, ENSG00000070371, P53675 |
| CMKOR1 | chemokine orphan receptor 1 | 57007 | 2 | 2q37.3 | T | 57007, CCDS2516.1, CMKOR1, CXCR7, ENSG00000144476, GPR159, P25106, RDC1 |
| COL1A1 | collagen, type I, alpha 1 | 1277 | 17 | 17q21.31-q22 | T | 1277, CCDS11561.1, COL1A1, ENSG00000108821, OI4, P02452, Q6LAN8, Q9UMA6 |
| COPEB | core promoter element binding protein (KLF6) | 1316 | 10 | 10p15 | Mis, N | 1316, BCD1, CCDS7060.1, COPEB, CPBP, DKFZp686N0199, ENSG00000067082, GBF, KLF6, PAC1, RP11-184A2_1, ST12, ZF9, Zf9 |
| COX6C | cytochrome c oxidase subunit VIc | 1345 | 8 | 8q22-q23 | T | 1345, CCDS6284.1, COX6C, ENSG00000164919, P09669 |
| CREB1 | cAMP responsive element binding protein 1 | 1385 | 2 | 2q34 | T | 1385, CREB1, ENSG00000118260 |
| CREB3L1 | cAMP responsive element binding protein 3-like 1 | 90993 | 11 | 11p11.2 | T | 90993, B2RA75, CREB3L1, ENSG00000157613, OASIS, Q96BA8 |
| CREB3L2 | cAMP responsive element binding protein 3-like 2 | 64764 | 7 | 7q34 | T | 64764, A2RRN1, BBF2H7, CCDS34760.1, CREB3L2, ENSG00000182158, MGC131709, MGC71006, Q6ZMR6, Q70SY1, Q8IY69, TCAG_1951439 |
| CREBBP | CREB binding protein (CBP) | 1387 | 16 | 16p13.3 | T, N, F, Mis, O | 1387, CBP, CCDS10509.1, CREBBP, ENSG00000005339, RSTS, RTS |
| CRLF2 | cytokine receptor-like factor 2 | 64109 | X,Y | Xp22.3; Yp11.3 | Mis, T | CRLF2, ENSG00000205755, Q4V300 |
| CRTC3 | CREB regulated transcription coactivator 3 | 64784 | 15 | 15q26.1 | T | 64784, CCDS32331.1, CRTC3, ENSG00000140577, FLJ21868, Q6DK61, Q6DK62, Q6UUV7, Q8TEF4, Q9H6U2, TORC3 |
| CTNNB1 | catenin (cadherin-associated protein), beta 1 | 1499 | 3 | 3p22-p21.3 | H, Mis, T | 1499, CCDS2694.1, CTNNB, CTNNB1, ENSG00000168036, P35222 |
| CYLD | familial cylindromatosis gene | 1540 | 16 | 16q12-q13 | Mis, N, F, S | 1540, CDMT, CYLD, CYLD1, CYLDI, EAC, ENSG00000083799, FLJ20180, FLJ31664, HSPC057, KIAA0849, USPL2 |
| D10S170 | DNA segment on chromosome 10 (unique) 170, H4 gene (PTC1) | 8030 | 10 | 10q21 | T | |
| DAXX | death-domain associated protein | 1616 | 6 | 6p21.3 | Mis, F, N | 1616, A2AB94, BING2, CCDS4776.1, DAP6, DAQB-126H3_2, DAXX, ENSG00000206206, MGC126245, MGC126246, Q4VX54, Q53F85, Q59FG7, Q5STK9, Q5STR5, Q9UER7 |
| DDB2 | damage-specific DNA binding protein 2 | 1643 | 11 | 11p12 | Mis, N | 1643, CCDS7927.1, DDB2, ENSG00000134574, FLJ34321, Q92466 |
| DDIT3 | DNA-damage-inducible transcript 3 | 1649 | 12 | 12q13.1-q13.2 | T | 1649, CCDS8943.1, CEBPZ, CHOP, CHOP10, DDIT3, ENSG00000175197, GADD153, MGC4154, P35638, Q53YD1, _C/EBP zeta_ |
| DDX10 | DEAD (Asp-Glu-Ala-Asp) box polypeptide 10 | 1662 | 11 | 11q22-q23 | T | 1662, CCDS8342.1, DDX10, ENSG00000178105, HRH-J8, Q13206, Q59EC7, Q86VR6 |
| DDX5 | DEAD (Asp-Glu-Ala-Asp) box polypeptide 5 | 1655 | 17 | 17q21 | T | 1655, CCDS11659.1, DDX5, DKFZp686J01190, ENSG00000108654, G17P1, HLR1, HUMP68, P17844, Q7Z2V5, p68 |
| DDX6 | DEAD (Asp-Glu-Ala-Asp) box polypeptide 6 | 1656 | 11 | 11q23.3 | T | 1656, DDX6, ENSG00000110367, FLJ36338, HLR2, P26196, P54, Q8IV96, RCK |
| DEK | DEK oncogene (DNA binding) | 7913 | 6 | 6p23 | T | 7913, CCDS34344.1, D6S231E, DEK, ENSG00000124795, P35659 |
| DICER1 | dicer 1, ribonuclease type III | 23405 | 14 | 14q32.13 | Mis F, N | 23405, CCDS9931.1, DICER1, Dicer, ENSG00000100697, HERNA, K12H4_8-LIKE, KIAA0928, Q5D0K4, Q5D0K5, Q9UFF3, Q9UPY3 |
| DNM2 | dynamin 2 | 1785 | 19 | 19p13.2 | F, N, Splice, Mis, O | 1785, CCDS32907.1, CMTDI1, CMTDIB, DNM2, DYN2, DYNII, ENSG00000079805, Q9UPH5 |
| DNMT3A | DNA (cytosine-5-)-methyltransferase 3 alpha | 1788 | 2 | 2p23 | Mis, F, N, S | 1788, CCDS33157.1, DNMT3A, DNMT3A2, ENSG00000119772, M_HsaIIIA, Q59HC6, Q6PJ37, Q86TE8, Q86XF5, Q8IZV0, Q8WVA9, Q9Y6K1 |
| DUX4 | double homeobox, 4 | 22947 | 4 | 4q35 | T | CCDS54828, DUX4, E0YLM6, F5GZ66, F8QWU0, F8QWU1, F8QWU2, P0CJ85, P0CJ86, P0CJ88, P0CJ89, P0CJ90, Q13060, Q14546, Q14547 |
| EBF1 | early B-cell factor 1 | 1879 | 5 | 5q34 | T | 1879, CCDS4343.1, COE1, EBF, EBF1, ENSG00000164330, O/E-1, OLF1, Q9UH73 |
| ECT2L | epithelial cell transforming sequence 2 oncogene-like | 345930 | 6 | 6q24.1 | N, Splice, Mis | 345930, C6orf91, CCDS43508.1, ECT2L, ENSG00000203734, LFDH, Q008S8, dJ509I19_2, dJ509I19_3 |
| EGFR | epidermal growth factor receptor (erythroblastic leukemia viral (v-erb-b) oncogene homolog, avian) | 1956 | 7 | 7p12.3-p12.1 | A, O, Mis | 1956, CCDS5514.1, EGFR, ENSG00000146648, ERBB, ERBB1, P00533, mENA |
| EIF4A2 | eukaryotic translation initiation factor 4A, isoform 2 | 1974 | 3 | 3q27.3 | T | 1974, BM-010, CCDS3282.1, DDX2B, EIF4A, EIF4A2, EIF4F, ENSG00000156976 |
| ELF4 | E74-like factor 4 (ets domain transcription factor) | 2000 | X | Xq26 | T | 2000, CCDS14617.1, ELF4, ELFR, ENSG00000102034, MEF, Q5H9H5, Q99607, RP3-510O21_2 |
| ELK4 | ELK4, ETS-domain protein (SRF accessory protein 1) | 2005 | 1 | 1q32 | T | 2005, CCDS1456.1, ELK4, ENSG00000158711, P28324, Q8IXL1, SAP1 |
| ELKS | ELKS protein | 23085 | 12 | 12p13.3 | T | 23085, A2RU77, CCDS8508.1, Cast2, ELKS, ENSG00000082805, ERC1, KIAA108, KIAA1081, MGC12974, Q8IUD2, RAB6IP2 |
| ELL | ELL gene (11-19 lysine-rich leukemia gene) | 8178 | 19 | 19p13.1 | T | 8178, C19orf17, CCDS12380.1, ELL, ELL1, ENSG00000105656, Men, P55199, Q59HG4, Q75MS0 |
| ELN | elastin | 2006 | 7 | 7q11.23 | T | 2006, CCDS5562.2, ELN, ENSG00000049540, FLJ38671, FLJ43523, Q9UMK5, SVAS, WBS, WS |
| EML4 | echinoderm microtubule associated protein like 4 | 27436 | 2 | 2p21 | T | 27436, EML4, ENSG00000143924 |
| EP300 | 300 kd E1A-Binding protein gene | 2033 | 22 | 22q13 | T, N, F, Mis, O | 2033, CCDS14010.1, ENSG00000100393, EP300, RP1-85F18_1, p300 |
| EPS15 | epidermal growth factor receptor pathway substrate 15 (AF1p) | 2060 | 1 | 1p32 | T | 2060, AF-1P, AF1P, CCDS557.1, ENSG00000085832, EPS15, MLLT5, P42566 |
| ERBB2 | v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian) | 2064 | 17 | 17q21.1 | A, Mis, O | 2064, ENSG00000141736, ERBB2, HER-2, HER-2/neu, HER2, NEU, NGL, P04626, TKR1, c-erb B2, c-erbB2 |
| ERCC2 | excision repair cross-complementing rodent repair deficiency, complementation group 2 (xeroderma pigmentosum D) | 2068 | 19 | 19q13.2-q13.3 | Mis, N, F, S | 2068, CCDS33049.1, COFS2, EM9, ENSG00000104884, ERCC2, MAG, MGC102762, MGC126218, MGC126219, P18074, Q2TB78, Q7KZU6, TTD, XPD |
| ERCC3 | excision repair cross-complementing rodent repair deficiency, complementation group 3 (xeroderma pigmentosum group B complementing) | 2071 | 2 | 2q21 | Mis, S | 2071, BTF2, CCDS2144.1, ENSG00000163161, ERCC3, GTF2H, P19447, Q53HW5, Q53QM0, RAD25, TFIIH, XPB |
| ERCC4 | excision repair cross-complementing rodent repair deficiency, complementation group 4 | 2072 | 16 | 16p13.3-p13.13 | Mis, N, F | 2072, A0PJA9, CCDS32390.1, ENSG00000175595, ERCC4, Q92889, RAD1, XPF |
| ERCC5 | excision repair cross-complementing rodent repair deficiency, complementation group 5 (xeroderma pigmentosum, complementation group G (Cockayne syndrome)) | 2073 | 13 | 13q33 | Mis, N, F | 2073, COFS3, ENSG00000134899, ERCC5, ERCM2, RP11-484I6_5, UVDR, XPG, XPGC |
| ERG | v-ets erythroblastosis virus E26 oncogene like (avian) | 2078 | 21 | 21q22.3 | T | 2078, CCDS13657.1, ERG, P11308 |
| ETV1 | ets variant gene 1 | 2115 | 7 | 7p22 | T | 2115, DKFZp781L0674, ENSG00000006468, ER81, ETV1, MGC104699, MGC120533, MGC120534 |
| ETV4 | ets variant gene 4 (E1A enhancer binding protein, E1AF) | 2118 | 17 | 17q21 | T | 2118, CCDS11465.1, E1A-F, E1AF, ENSG00000175832, ETV4, PEA3, PEAS3 |
| ETV5 | ets variant gene 5 | 2119 | 3 | 3q28 | T | 2119, CCDS33906.1, ENSG00000244405, ERM, ETV5, P41161, Q6IBN5 |
| ETV6 | ets variant gene 6 (TEL oncogene) | 2120 | 12 | 12p13 | T | 2120, CCDS8643.1, ENSG00000139083, ETV6, P41212, Q9UME7, TEL, TEL/ABL |
| EVI1 | ecotropic viral integration site 1 | 2122 | 3 | 3q26 | T | 2122, A1L4F3, CCDS3205.1, ENSG00000085276, EVI1, MDS1-EVI1, MECOM, PRDM3, Q03112, Q5HYI1, Q6MZS6, Q8IU84, Q8NEI5 |
| EWSR1 | Ewing sarcoma breakpoint region 1 (EWS) | 2130 | 22 | 22q12 | T | 2130, CCDS13851.1, ENSG00000182944, EWS, EWSR1 |
| EXT1 | multiple exostoses type 1 gene | 2131 | 8 | 8q24.11-q24.13 | Mis, N, F, S | 2131, CCDS6324.1, ENSG00000182197, EXT, EXT1, Q16394, ttv |
| EXT2 | multiple exostoses type 2 gene | 2132 | 11 | 11p12-p11 | Mis, N, F, S | 2132, CCDS7908.1, ENSG00000151348, EXT2, Q6NUL1, Q93063, SOTV |
| EZH2 | enhancer of zeste homolog 2 | 2146 | 7 | 7q35-q36 | Mis | 2146, B2RAQ1, B3KS30, CCDS5891.1, CCDS5892, ENSG00000106462, ENX-1, ENX1, EZH1, EZH2, EZH2_ENST00000350995, KMT6, MGC9169, Q15910, Q6R125, Q75MG3, Q75MP9, Q75MQ0, Q96FI6 |
| EZR | ezrin | 7430 | 6 | 6q25.3 | T | 7430, CCDS5258.1, CVIL, CVL, DKFZp762H157, ENSG00000092820, EZR, FLJ26216, MGC1584, P15311, Q6NUR7, Q9UJZ2, Q9UJZ6, Q9UJZ7, Q9UJZ8, Q9UK20 |
| FACL6 | fatty-acid-coenzyme A ligase, long-chain 6 | 23305 | 5 | 5q31 | T | 23305, ACS2, ACSL6, CCDS34228.1, ENSG00000164398, FACL6, KIAA0837, LACS2, LACS5 |
| FAM22A | family with sequence similarity 22, member A | 728118 | 10 | 10q23.2 | T | ENSG00000214562, FAM22A, FAM22D |
| FAM22B | family with sequence similarity 22, member B | 729262 | 10 | 10q22.3 | T | |
| FAM46C | family with sequence similarity 46, member C | 54855 | 1 | 1p12 | Mis, F, O | 54855, A3KMG2, CCDS896.1, ENSG00000183508, FAM46C, FLJ20202, Q5VWP2 |
| FANCA | Fanconi anemia, complementation group A | 2175 | 16 | 16q24.3 | D, Mis, N, F, S | 2175, ENSG00000187741, FA, FA-H, FA1, FAA, FACA, FAH, FANCA, FANCH, MGC75158 |
| FANCC | Fanconi anemia, complementation group C | 2176 | 9 | 9q22.3 | D, Mis, N, F, S | 2176, ENSG00000158169, FA3, FAC, FACC, FANCC, FLJ14675, RP11-80I15_2 |
| FANCD2 | Fanconi anemia, complementation group D2 | 2177 | 3 | 3p26 | D, Mis, N, F | 2177, CCDS2595.1, DKFZp762A223, ENSG00000144554, FA-D2, FA4, FACD, FAD, FAD2, FANCD, FANCD2, FLJ23826 |
| FANCE | Fanconi anemia, complementation group E | 2178 | 6 | 6p21-p22 | N, F, S | 2178, CCDS4805.1, ENSG00000112039, FACE, FAE, FANCE |
| FANCF | Fanconi anemia, complementation group F | 2188 | 11 | 11p15 | N, F | 2188, CCDS7857.1, ENSG00000183161, FAF, FANCF, MGC126856, Q53FK7, Q6MZN0, Q9NPI8 |
| FANCG | Fanconi anemia, complementation group G | 2189 | 9 | 9p13 | Mis, N, F, S | 2189, CCDS6574.1, ENSG00000221829, FAG, FANCG, O15287, Q53XM5, XRCC9 |
| FBXO11 | F-box protein 11 | 80204 | 2 | 2p16.3 | Mis, F, D | 80204, A1L491, CCDS1837.1, ENSG00000138081, FBX11, FBXO11, FLJ12673, MGC44383, PRMT9, Q53RT5, Q86XK2, UG063H01, VIT1 |
| FBXW7 | F-box and WD-40 domain protein 7 (archipelago homolog, Drosophila) | 55294 | 4 | 4q31.3 | Mis, N, D, F | 55294, AGO, CCDS3777.1, CCDS3778.1, CDC4, DKFZp686F23254, ENSG00000109670, FBW7, FBX30, FBXW6, FBXW7, FBXW7_NM_018315_2, FLJ11071, SEL-10, SEL10 |
| FCGR2B | Fc fragment of IgG, low affinity IIb, receptor for (CD32) | 2213 | 1 | 1q23 | T | 2213, CCDS30924.1, CD32, CD32B, ENSG00000072694, FCG2, FCGR2, FCGR2B, IGFR2, P31994, Q8IU78, Q8IU79, Q8IXE8, Q8IXE9, Q8IZV7, Q8NI89, Q8NIA0 |
| FEV | FEV protein - (HSRNAFEV) | 54738 | 2 | 2q36 | T | 54738, CCDS2428.1, ENSG00000163497, FEV, HSRNAFEV, PET-1, Pet-1 |
| FGFR1 | fibroblast growth factor receptor 1 | 2260 | 8 | 8p11.2-p11.1 | T | 2260, BFGFR, CD331, CEK, ENSG00000077782, FGFBR, FGFR1, FLG, FLT2, H2, H3, H4, H5, HBGFR, KAL2, N-SAM, P11362 |
| FGFR1OP | FGFR1 oncogene partner (FOP) | 11116 | 6 | 6q27 | T | 11116, CCDS5297.1, ENSG00000213066, FGFR1OP, FOP |
| FGFR2 | fibroblast growth factor receptor 2 | 2263 | 10 | 10q26 | Mis | 2263, BEK, BFR-1, CD332, CEK3, CFD1, ECT1, ENSG00000066468, FGFR2, JWS, K-SAM, KGFR, TK14, TK25 |
| FGFR3 | fibroblast growth factor receptor 3 | 2261 | 4 | 4p16.3 | Mis, T | 2261, ACH, CCDS3353.1, CD333, CEK2, ENSG00000068078, FGFR3, HSFGFR3EX, JTK4, P22607 |
| FH | fumarate hydratase | 2271 | 1 | 1q42.1 | Mis, N, F | 2271, CCDS1617.1, ENSG00000091483, FH, HLRCC, LRCC, MCL, MCUL1, P07954, Q5SY06 |
| FHIT | fragile histidine triad gene | 2272 | 3 | 3p14.2 | T | 2272, A2IAS9, A2IAT6, AP3Aase, CCDS2894.1, ENSG00000189283, FHIT, FRA3B, O00298, P49789, Q0MQR8, Q0PUW1, Q194U8, Q194V0, Q1WAB3, Q45QG9, Q5G284, Q71VB2 |
| FIP1L1 | FIP1 like 1 (S. cerevisiae) | 81608 | 4 | 4q12 | T | 81608, CCDS3491.1, DKFZp586K0717, ENSG00000145216, FIP1L1, Q6UN15 |
| FLI1 | Friend leukemia virus integration 1 | 2313 | 11 | 11q24 | T | 2313, ENSG00000151702, EWSR2, FLI1, Q01543, SIC-1 |
| FLJ27352 | BX648577, FLJ27352 hypothetical LOC145788 | 145788 | 15 | 15q21.3 | T | |
| FLT3 | fms-related tyrosine kinase 3 | 2322 | 13 | 13q12 | Mis, O | 2322, CD135, ENSG00000122025, FLK2, FLT3, P36888, RP11-153M24_3, STK1 |
| FNBP1 | formin binding protein 1 (FBP17) | 23048 | 9 | 9q23 | T | 8412, BCAR3, ENSG00000137936, FNBP1, KIAA0554, NSP2, SH2D3B |
| FOXL2 | forkhead box L2 | 668 | 3 | 3q23 | Mis | 668, BPES, BPES1, CCDS3105.1, ENSG00000183770, FOXL2, P58012, PFRK, PINTO, POF3, Q05CX9, Q4JHB5, Q4JHB7, Q53ZD3 |
| FOXO1A | forkhead box O1A (FKHR) | 2308 | 13 | 13q14.1 | T | 2308, CCDS9371.1, ENSG00000150907, FKH1, FKHR, FOXO1, FOXO1A, Q12778 |
| FOXO3A | forkhead box O3A | 2309 | 6 | 6q21 | T | 2309, AF6q21, CCDS5068.1, DKFZp781A0677, ENSG00000118689, FKHRL1, FKHRL1P2, FOXO2, FOXO3, FOXO3A, MGC12739, MGC31925, O43524, Q68DV3, Q9UPC2 |
| FOXP1 | forkhead box P1 | 27086 | 3 | 3p14.1 | T | 12CC4, 27086, CCDS2914.1, ENSG00000114861, FLJ23741, FOXP1, HSPC215, MGC12942, MGC88572, MGC99551, QRF1, hFKH1B |
| FSTL3 | follistatin-like 3 (secreted glycoprotein) | 10272 | 19 | 19p13 | T | 10272, CCDS12040.1, ENSG00000070404, FLRG, FSTL3, O95633 |
| FUBP1 | far upstream element (FUSE) binding protein 1 | 8880 | 1 | 1p13.1 | F, N | 8880, CCDS683.1, ENSG00000162613, FBP, FUBP, FUBP1 |
| FUS | fusion, derived from t(12;16) malignant liposarcoma | 2521 | 16 | 16p11.2 | T | 2521, CCDS10707.1, CHOP, ENSG00000089280, FUS, FUS-CHOP, FUS1, P35637, Q13344, Q6IBQ5, Q8TBR3, TLS, TLS/CHOP |
| FVT1 | follicular lymphoma variant translocation 1 | 2531 | 18 | 18q21.3 | T | 2531, CCDS11982.1, ENSG00000119537, FVT1, KDSR, Q06136 |
| GAS7 | growth arrest-specific 7 | 8522 | 17 | 17p | T | 8522, CCDS11152.1, ENSG00000007237, GAS7, KIAA0394, MGC1348, MLL/GAS7, O60861, Q29RX5, Q53Y77, Q59GS9, Q7Z571 |
| GATA1 | GATA binding protein 1 (globin transcription factor 1) | 2623 | X | Xp11.23 | Mis, F | 2623, CCDS14305.1, ENSG00000102145, ERYF1, GATA1, GF1, NFE1, P15976 |
| GATA2 | GATA binding protein 2 | 2624 | 3 | 3q21.3 | Mis | 2624, CCDS3049.1, ENSG00000179348, GATA2, MGC2306, NFE1B, P23769, Q53YE0, Q96BH0, Q96BH8 |
| GATA3 | GATA binding protein 3 | 2625 | 10 | 10p15 | F, N, S | 2625, CCDS31143.1, ENSG00000107485, GATA3, HDR, MGC2346, MGC5199, MGC5445, Q5VWG7 |
| GMPS | guanine monphosphate synthetase | 8833 | 3 | 3q24 | T | 8833, ENSG00000163655, GMPS |
| GNA11 | guanine nucleotide binding protein (G protein), alpha 11 (Gq class) | 2767 | 19 | 19p13.3 | Mis | 2767, CCDS12103.1, ENSG00000088256, GNA-11, GNA11 |
| GNAQ | guanine nucleotide binding protein (G protein), q polypeptide | 2776 | 9 | 9q21 | Mis | 2776, CCDS6658.1, ENSG00000156052, G-ALPHA-q, GAQ, GNAQ, P50148, Q5T8F3, Q6NT27, RP11-494N1_1 |
| GNAS | guanine nucleotide binding protein (G protein), alpha stimulating activity polypeptide 1 | 2778 | 20 | 20q13.2 | Mis | 2778, AHO, C20orf45, CCDS13471.1, ENSG00000087460, GNAS, GNAS1, GNASXL, GNAS_NM_016592_1, GPSA, GSA, GSP, Gnas, MGC33735, NESP, NESP55, PHP1A, PHP1B, POH, RP4-543J19_4, SCG6, XL, XL2, XLalphas, dJ309F20_1_1, dJ806M20_3_3 |
| GOLGA5 | golgi autoantigen, golgin subfamily a, 5 (PTC5) | 9950 | 14 | 14q | T | 9950, CCDS9905.1, ENSG00000066455, GOLGA5, Q2TS49, Q8TBA6, golgin-84, ret-II, rfg5 |
| GOPC | golgi associated PDZ and coiled-coil motif containing | 57120 | 6 | 6q21 | O | 57120, CAL, CCDS5117.1, ENSG00000047932, FIG, GOPC, GOPC1, Q9HD26, dJ94G16_2 PIST |
| GPC3 | glypican 3 | 2719 | X | Xq26.1 | T, D, Mis, N, F, S | 2719, AC002420_1, CCDS14638.1, DGSX, ENSG00000147257, GPC3, OCI-5, P51654, Q1MTS4, Q2L880, Q53H15, Q8IYG2, SDYS, SGB, SGBS, SGBS1 |
| GPHN | gephyrin (GPH) | 10243 | 14 | 14q24 | T | 10243, CCDS9777.1, ENSG00000171723, GPHN |
| GRAF | GTPase regulator associated with focal adhesion kinase pp125(FAK) | 23092 | 5 | 5q31 | T, F, S | 23092, ARHGAP26, ENSG00000145819, FLJ42530, GRAF, KIAA0621, OPHN1L, OPHN1L1 |
| H3F3A | H3 histone, family 3A | 3020 | 1 | 1q42.12 | Mis | 3020, CCDS1550.1, ENSG00000163041, H3F3, H3F3A, H3_3A, H3_3B, LOC347376, MGC87782, MGC87783, P84243, Q6TXQ4 |
| HCMOGT-1 | sperm antigen HCMOGT-1 | 92521 | 17 | 17p11.2 | T | 92521, CCDS32590.1, CYTSB, ENSG00000128487, FLJ36955, HCMOGT-1, NSP, Q5M775, SPECC1 |
| HEAB | ATP_GTP binding protein | 10978 | 11 | 11q12 | T | 10978, CCDS7964.1, CLP1, ENSG00000172409, HEAB, Q92989, hClp1 |
| HERPUD1 | homocysteine-inducible, endoplasmic reticulum stress-inducible, ubiquitin-like domain member 1 | 9709 | 16 | 16q12.2-q13 | T | 9709, A4UAE9, CCDS10771.1, ENSG00000051108, HERP, HERPUD1, KIAA0025, Mif1, Q15011, Q53FP9, Q6IAN8, Q9HBR2, SUP |
| HEY1 | hairy/enhancer-of-split related with YRPW motif 1 | 23462 | 8 | 8q21 | T | 23462, CCDS6225.1, CHF-2, CHF2, ENSG00000164683, HERP2, HESR-1, HESR1, HEY1, HRT-1, MGC1274, OAF1 |
| HIP1 | huntingtin interacting protein 1 | 3092 | 7 | 7q11.23 | T | 3092, ENSG00000127946, HIP1, ILWEQ, Q8TDA4 |
| HIST1H4I | histone 1, H4i (H4FM) | 8294 | 6 | 6p21.3 | T | 8294, CCDS4620.1, HIST1H4I, HIST4H4, MGC24116, P62805, Q0VAS5, Q6B823, Q6DRA9, Q6FGB8, Q6NWP7 |
| HLF | hepatic leukemia factor | 3131 | 17 | 17q22 | T | 3131, CCDS11585.1, ENSG00000108924, HLF, Q16534, Q6FHS9 |
| HLXB9 | homeo box HB9 | 3110 | 7 | 7q36 | T | 3110, CCDS34788.1, ENSG00000130675, HB9, HLXB9, MNX1, P50219, Q9UDY3 |
| HMGA1 | high mobility group AT-hook 1 | 3159 | 6 | 6p21 | T | 3159, CCDS4789.1, ENSG00000137309, HMG-R, HMGA1, HMGIY, MGC12816, MGC4242, MGC4854, P17096, Q5T6U9 |
| HMGA2 | high mobility group AT-hook 2 (HMGIC) | 8091 | 12 | 12q15 | T | 8091, BABL, ENSG00000149948, HMGA2, HMGI-C, HMGIC, LIPO |
| HNRNPA2B1 | heterogeneous nuclear ribonucleoprotein A2/B1 | 3181 | 7 | 7p15 | T | 3181, CCDS5397.1, ENSG00000122566, HNRNPA2, HNRNPA2B1, HNRNPB1, HNRPA2, HNRPB1, RNPA2, SNRPB1 |
| HOOK3 | hook homolog 3 | 84376 | 8 | 8p11.21 | T | 84376, CCDS6139.1, ENSG00000168172, HK3, HOOK3, Q86VS8 |
| HOXA11 | homeo box A11 | 3207 | 7 | 7p15-p14.2 | T | 3207, CCDS5411.1, ENSG00000005073, HOX1, HOX1I, HOXA11, P31270 |
| HOXA13 | homeo box A13 | 3209 | 7 | 7p15-p14.2 | T | 3209, CCDS5412.1, ENSG00000106031, HOX1, HOX1J, HOXA13, P31271, Q6DI00 |
| HOXA9 | homeo box A9 | 3205 | 7 | 7p15-p14.2 | T | 3205, CCDS5409.1, ENSG00000078399, HOX1, HOX1G, HOXA9, P31269 |
| HOXC11 | homeo box C11 | 3227 | 12 | 12q13.3 | T | 3227, CCDS8867.1, ENSG00000123388, HOX3H, HOXC11, O43248 |
| HOXC13 | homeo box C13 | 3229 | 12 | 12q13.3 | T | 3229, CCDS8865.1, ENSG00000123364, HOX3, HOX3G, HOXC13, P31276, Q6LAM3 |
| HOXD11 | homeo box D11 | 3237 | 2 | 2q31-q32 | T | 3237, CCDS2265.1, ENSG00000128713, HOXD11 |
| HOXD13 | homeo box D13 | 3239 | 2 | 2q31-q32 | T | 3239, CCDS2264.1, HOX4I, HOXD13, P35453, SPD |
| HRAS | v-Ha-ras Harvey rat sarcoma viral oncogene homolog | 3265 | 11 | 11p15.5 | Mis | 3265, CCDS7698.1, ENSG00000174775, HRAS, HRAS1, K-ras, N-ras, P01112, RASH1, c-bas/has |
| HRPT2 | hyperparathyroidism 2 | 3279 | 1 | 1q21-q31 | Mis, N, F | 79577, C1orf28, CCDS1382.1, CDC73, ENSG00000134371, FLJ23316, HPT-JT, HRPT2, Q6P1J9, Q6PHR8 |
| HSPCA | heat shock 90kDa protein 1, alpha | 3320 | 14 | 14q32.31 | T | 3320, CCDS32160.1, ENSG00000080824, FLJ31884, HSP86, HSP90A, HSP90AA1, HSP90N, HSPC1, HSPCA, HSPCAL1, HSPCAL4, HSPN, Hsp89, Hsp90, LAP2, O75322, P07900, Q14568, Q2VPJ6, Q5CAQ6, Q5CAQ7, Q86SX1, Q86U12, Q8TBA7, Q96HX7 |
| HSPCB | heat shock 90kDa protein 1, beta | 3326 | 6 | 6p12 | T | 3326, CCDS4909.1, D6S182, ENSG00000096384, FLJ26984, HSP90-BETA, HSP90AB1, HSP90B, HSPC2, HSPCB, P08238, Q6PK50, Q9H6X9 |
| IDH1 | isocitrate dehydrogenase 1 (NADP+), soluble | 3417 | 2 | 2q33.3 | Mis | 3417, CCDS2381.1, ENSG00000138413, IDH, IDH1, IDP, O75874, PICD, Q0QER2, Q567U4, Q6FHQ6, Q6FI37, Q6FIA4, Q7Z3V0 |
| IDH2 | socitrate dehydrogenase 2 (NADP+), mitochondrial | 3418 | 15 | 15q26.1 | M | 3418, CCDS10359.1, ENSG00000182054, ICD-M, IDH, IDH2, IDHM, IDP, P48735, Q53GL5, mNADP-IDH |
| IGH@ | immunoglobulin heavy locus | 3492 | 14 | 14q32.33 | T | |
| IGK@ | immunoglobulin kappa locus | 50802 | 2 | 2p12 | T | |
| IGL@ | immunoglobulin lambda locus | 3535 | 22 | 22q11.1-q11.2 | T | |
| IKZF1 | IKAROS family zinc finger 1 | 10320 | 7 | 7p12.2 | D,T | 10320, ENSG00000185811, Hs_54452, IKAROS, IKZF1, LyF-1, Q13422, ZNFN1A1, hIk-1 |
| IL2 | interleukin 2 | 3558 | 4 | 4q26-q27 | T | 3558, CCDS3726.1, ENSG00000109471, IL-2, IL2, P60568, Q0GK43, Q13169, Q16334, Q309Q7, Q6NZ91, Q6NZ93, Q6QWN0, Q71V48, Q7Z7M3, Q8NFA4, Q9C001 |
| IL21R | interleukin 21 receptor | 50615 | 16 | 16p11 | T | 50615, CCDS10630.1, ENSG00000103522, IL21R, Q9HBE5 |
| IL6ST | interleukin 6 signal transducer (gp130, oncostatin M receptor) | 3572 | 5 | 5q11 | O | 3572, A0N0L4, CCDS3971.1, CD130, CDw130, ENSG00000134352, GP130, GP130-RAPS, IL6R-beta, IL6ST, P40189, Q17RA0 |
| IL7R | interleukin 7 receptor | 146661 | 5 | 5p13 | Mis, O | 3575, CCDS3911.1, CD127, CDW127, ENSG00000168685, IL-7R-alpha, IL7R, P16871, Q05CU8, Q6NSP4, Q6NWM0, Q6NWM1, Q6NWM2, Q6NWM3 |
| IRF4 | interferon regulatory factor 4 | 3662 | 6 | 6p25-p23 | T | 3662, CCDS4469.1, ENSG00000137265, IRF4, LSIRF, MUM1, Q15306 |
| IRTA1 | immunoglobulin superfamily receptor translocation associated 1 | 83417 | 1 | 1q21 | T | 83417, CCDS1166.1, ENSG00000163518, FCRH4, FCRL4, IGFP2, IRTA1, Q96PJ5, Q96RE0 |
| ITK | IL2-inducible T-cell kinase | 3702 | 5 | 5q31-q32 | T | 3702, CCDS4336.1, EMT, ENSG00000113263, ITK, LYK, MGC126257, MGC126258, PSCTK2, Q08881 |
| JAK1 | Janus kinase 1 | 3716 | 1 | 1p32.3-p31.3 | Mis | 3716, CCDS41346, ENSG00000162434, JAK1, JAK1A, JAK1B, JAK1_ENST00000342505, JTK3, P23458, Q0VGA4, Q4LDX3, Q6P669, Q8IV82 |
| JAK2 | Janus kinase 2 | 3717 | 9 | 9p24 | T, Mis, O | 3717, A8K910, A9QVL8, B4DYV1, CCDS6457, ENSG00000096968, JAK2, JAK2_ENST00000381652, JTK10, O60674, Q506Q0, Q52R86, Q8IXP2 |
| JAK3 | Janus kinase 3 | 3718 | 19 | 19p13.1 | Mis | 3718, CCDS12366.1, ENSG00000105639, JAK-3, JAK3, JAK3_HUMAN, JAKL, L-JAK, LJAK, P52333 |
| JAZF1 | juxtaposed with another zinc finger gene 1 | 221895 | 7 | 7p15.2-p15.1 | T | 221895, CCDS5416.1, ENSG00000153814, JAZF1, Q69YN3, Q86VZ6 |
| JUN | jun oncogene | 3725 | 1 | 1p32-p31 | A | 3725, AP1, CCDS610.1, ENSG00000177606, JUN, P05412, Q6FHK0, Q6FHM7, c-Jun |
| KDM5A | lysine (K)-specific demethylase 5A, JARID1A | 5927 | 12 | 12p11 | T | 5927, ENSG00000073614, JARID1A, KDM5A, RBBP2, RBP2 |
| KDM5C | lysine (K)-specific demethylase 5C (JARID1C) | 8242 | X | Xp11.22-p11.21 | N, F, S | 8242, DXS1272E, ENSG00000126012, JARID1C, KDM5C, MRXJ, MRXSJ, RP11-258C19_2, SMCX, XE169 |
| KDM6A | lysine (K)-specific demethylase 6A, UTX | 7403 | X | Xp11.2 | D, N, F, S | 7403, CCDS14265.1, DKFZp686A03225, ENSG00000147050, KDM6A, MGC141941, O15550, Q52LL9, Q590H7, Q59HG3, Q5JV43, Q68D33, Q6N053, RP13-886N14_3, UTX, bA386N14_2 |
| KDR | vascular endothelial growth factor receptor 2 | 3791 | 4 | 4q11-q12 | Mis | 3791, CCDS3497.1, CD309, ENSG00000128052, FLK1, KDR, P35968, VEGFR, VEGFR2 |
| KIAA1549 | KIAA1549 | 57670 | 7 | 7q34 | O | 57670, ENSG00000122778, KIAA1549 |
| KIF5B | kinesin family member 5B | 3799 | 10 | 10p11.22 | T | 3799, CCDS7171.1, ENSG00000170759, KIF5B, KINH, KNS, KNS1, P33176, Q2TA90, Q66K46, Q6P164, UKHC |
| KIT | v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog | 3815 | 4 | 4q12 | Mis, O | 3815, C-Kit, CD117, ENSG00000157404, KIT, P10721, SCFR |
| KLK2 | kallikrein-related peptidase 2 | 3817 | 19 | 19q13.41 | T | 3817, CCDS12808.1, ENSG00000167751, KLK2, KLK2A2, MGC12201, P20151, Q6T775, hK2 |
| KRAS | v-Ki-ras2 Kirsten rat sarcoma 2 viral oncogene homolog | 3845 | 12 | 12p12.1 | Mis | 3845, C-K-RAS, CCDS8702.1, K-RAS2A, K-RAS2B, K-RAS4A, K-RAS4B, KI-RAS, KRAS, KRAS1, KRAS2, NS3, P01116, RASK2 |
| KTN1 | kinectin 1 (kinesin receptor) | 3895 | 14 | 14q22.1 | T | 3895, CCDS9725.1, CG1, ENSG00000126777, KIAA0004, KTN1, Q17RZ5, Q3SWV9, Q5GGW3, Q6NZ46, Q6PDF7, Q86UP2 |
| LAF4 | lymphoid nuclear protein related to AF4 | 3899 | 2 | 2q11.2-q12 | T | 3899, AFF3, CCDS33258.1, ENSG00000144218, LAF4, MLLT2-like, P51826 |
| LASP1 | LIM and SH3 protein 1 | 3927 | 17 | 17q11-q21.3 | T | 3927, CCDS11331.1, ENSG00000002834, LASP1, Lasp-1, MLN50, Q14847 |
| LCK | lymphocyte-specific protein tyrosine kinase | 3932 | 1 | 1p35-p34.3 | T | 3932, ENSG00000182866, LCK, P06239, YT16, p56lck, pp58lck |
| LCP1 | lymphocyte cytosolic protein 1 (L-plastin) | 3936 | 13 | 13q14.1-q14.3 | T | 3936, CCDS9403.1, CP64, DKFZp781A23186, ENSG00000136167, FLJ25423, FLJ26114, FLJ39956, L-PLASTIN, LC64P, LCP1, P13796, PLS2, Q53FI1, Q59GX5, Q5TBN3, Q5TBN4, Q5TBN5 |
| LCX | leukemia-associated protein with a CXXC domain | 80312 | 10 | 10q21 | T | 80312, CCDS7281.1, CXXC6, ENSG00000138336, KIAA1676, LCX, Q8NFU7, TET1, bA119F7_1 |
| LHFP | lipoma HMGIC fusion partner | 10186 | 13 | 13q12 | T | 10186, CCDS9369.1, ENSG00000183722, LHFP, MGC22429 |
| LIFR | leukemia inhibitory factor receptor | 3977 | 5 | 5p13-p12 | T | 3977, CCDS3927.1, CD118, ENSG00000113594, LIFR, SJS2, STWS, SWS |
| LMO1 | LIM domain only 1 (rhombotin 1) (RBTN1) | 4004 | 11 | 11p15 | T, A | 4004, ENSG00000166407, LMO1, P25800, Q8IXR0, RBTN1, RHOM1, TTG1 |
| LMO2 | LIM domain only 2 (rhombotin-like 1) (RBTN2) | 4005 | 11 | 11p13 | T | 4005, CCDS7888.1, ENSG00000135363, LMO2, P25791, RBTN2, RBTNL1, RHOM2, TTG2 |
| LPP | LIM domain containing preferred translocation partner in lipoma | 4026 | 3 | 3q28 | T | 4026, A1L4L6, CCDS3291.1, ENSG00000145012, LPP, Q93052 |
| LRIG3 | leucine-rich repeats and immunoglobulin-like domains 3 | 121227 | 12 | 12q14.1 | T | 121227, CCDS8960.1, ENSG00000139263, FLJ26573, FLJ90440, KIAA3016, LRIG3, Q6UXM1 |
| LYL1 | lymphoblastic leukemia derived sequence 1 | 4066 | 19 | 19p13.2-p13.1 | T | 4066, CCDS12292.1, ENSG00000104903, LYL1, P12980 |
| MADH4 | Homolog of Drosophila Mothers Against Decapentaplegic 4 gene | 4089 | 18 | 18q21.1 | D, Mis, N, F | 4089, CCDS11950.1, DPC4, ENSG00000141646, JIP, MADH4, Q13485, Q9BYG6, SMAD4 |
| MAF | v-maf musculoaponeurotic fibrosarcoma oncogene homolog | 4094 | 16 | 16q22-q23 | T | 4094, CCDS10928.1, ENSG00000178573, MAF, MGC71685 |
| MAFB | v-maf musculoaponeurotic fibrosarcoma oncogene homolog B (avian) | 9935 | 20 | 20q11.2-q13.1 | T | 9935, CCDS13311.1, ENSG00000204103, KRML, MAFB, MGC43127, Q9Y5Q3 |
| MALT1 | mucosa associated lymphoid tissue lymphoma translocation gene 1 | 10892 | 18 | 18q21 | T | 10892, CCDS11968.1, ENSG00000172175, MALT1 |
| MAML2 | mastermind-like 2 (Drosophila) | 84441 | 11 | 11q22-q23 | T | 84441, DKFZp686N0150, ENSG00000184384, KIAA1819, MAM-3, MAM2, MAM3, MAML2, MLL-MAML2, Q8IZL2 |
| MAP2K4 | mitogen-activated protein kinase kinase 4 | 6416 | 17 | 17p11.2 | D, Mis, N | 6416, CCDS11162.1, ENSG00000065559, JNKK, JNKK1, MAP2K4, MAPKK4, MEK4, MKK4, P45985, PRKMK4, SEK1, SERK1 |
| MDM2 | Mdm2 p53 binding protein homolog | 4193 | 12 | 12q15 | A | 4193, CCDS8986.1, ENSG00000135679, HDM2, HDMX, MDM2, MGC71221, Q00987, Q546E6, Q8NDV9, Q8WYJ3, Q96DS4, hdm2 |
| MDM4 | Mdm4 p53 binding protein homolog | 4194 | 1 | 1q32 | A | 4194, CCDS1447.1, DKFZp781B1423, ENSG00000198625, MDM4, MDMX, MGC132766, MRP1, RP11-430C7_1 |
| MDS1 | myelodysplasia syndrome 1 | 4197 | 3 | 3q26 | T | 4197, MDS1, MDS1-EVI1, PRDM3, Q13465, Q6FH90 |
| MDS2 | myelodysplastic syndrome 2 | 259283 | 1 | 1p36 | T | 259283, ENSG00000197880, MDS2, Q8NDY4 |
| MECT1 | mucoepidermoid translocated 1 | 94159 | 19 | 19p13 | T | 23373, CCDS32963.1, CRTC1, ENSG00000105662, FLJ14027, KIAA0616, MECT1, Q6UUV9, TORC1, WAMTP1 |
| MED12 | mediator complex subunit 12 | 9968 | X | Xq13 | M, S | 9968, ARC240, CAGH45, CCDS43970, FGS1, HOPA, KIAA0192, MED12, MED12_ENST00000374080, OKS, OPA1, Q7Z2E0, Q7Z2F1, Q7Z2F4, Q93074, TNRC11, TRAP230 |
| MEN1 | multiple endocrine neoplasia type 1 gene | 4221 | 11 | 11q13 | D, Mis, N, F, S | 4221, CCDS31600.1, ENSG00000133895, MEN1, Q9BUF0, Q9GZQ5, Q9UE24 |
| MET | met proto-oncogene (hepatocyte growth factor receptor) | 4233 | 7 | 7q31 | Mis | 4233, AUTS9, ENSG00000105976, HGFR, MET, P08581, RCCP2 |
| MITF | microphthalmia-associated transcription factor | 4286 | 3 | 3p14.1 | A | 4286, CCDS2913.1, ENSG00000187098, MITF, WS2A |
| MKL1 | megakaryoblastic leukemia (translocation) 1 | 57591 | 22 | 22q13 | T | 57591, A4FUJ8, BSAC, CCDS14003.1, ENSG00000196588, MAL, MKL1, MRTF-A, Q29R68, Q969V6 |
| MLF1 | myeloid leukemia factor 1 | 4291 | 3 | 3q25.1 | T | 4291, CCDS3182.1, ENSG00000178053, MLF1, P58340, Q2TLE3, Q2TLE4 |
| MLH1 | E.coli MutL homolog gene | 4292 | 3 | 3p21.3 | D, Mis, N, F, S | 4292, CCDS2663.1, COCA2, ENSG00000076242, FCC2, HNPCC, HNPCC2, MGC5172, MLH1, P40692, Q0ZAJ3, Q0ZAJ6, Q53GX1, Q5GJ64, Q64FK0, Q6VBB8, hMLH1 |
| MLL | myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila) | 4297 | 11 | 11q23 | T, O | 4297, ALL-1, CXXC7, ENSG00000118058, HRX, HTRX1, MLL, MLL/GAS7, MLL1A, TRX1 |
| MLL2 | myeloid/lymphoid or mixed-lineage leukemia 2 | 8085 | 12 | 12q12-q14 | N, F, Mis | 8085, ENSG00000167548, MLL2 |
| MLL3 | myeloid/lymphoid or mixed-lineage leukemia 3 | 58508 | 7 | 7q36.1 | N | 58508, ENSG00000055609, MLL3 |
| MLLT1 | myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 1 (ENL) | 4298 | 19 | 19p13.3 | T | 4298, CCDS12160.1, ENL, ENSG00000130382, LTG19, MLLT1, Q03111, YEATS1 |
| MLLT10 | myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 10 (AF10) | 8028 | 10 | 10p12 | T | 8028, AF10, CCDS7135.1, ENSG00000078403, MLLT10, O60696, P55197, Q59EQ6, Q71UR7 |
| MLLT2 | myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 2 (AF4) | 4299 | 4 | 4q21 | T | 4299, AF-4, AFF1, CCDS3616.1, ENSG00000172493, MLLT2, P51825, PBM1, Q05D98, Q14C88, Q6LA76, Q712L1 |
| MLLT3 | myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 3 (AF9) | 4300 | 9 | 9p22 | T | 4300, AF-9, AF9, CCDS6494.1, ENSG00000171843, MLLT3, P42568, Q5VV08, Q5VV09, Q6LEQ8, Q6MZE2, Q8IVB0, YEATS3 |
| MLLT4 | myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 4 (AF6) | 4301 | 6 | 6q27 | T | 4301, CCDS5303.1, ENSG00000130396, MLLT4, Q5TIG7, Q5TIH1, Q96C95 |
| MLLT6 | myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 6 (AF17) | 4302 | 17 | 17q21 | T | 4302, AF17, CCDS11327.1, ENSG00000108292, MLLT6, P55198, Q59F28, Q96IU3, Q9H5F6 |
| MLLT7 | myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 7 (AFX1) | 4303 | X | Xq13.1 | T | 4303, AFX1, ENSG00000184481, FOXO4, MLLT7, P98177 |
| MN1 | meningioma (disrupted in balanced translocation) 1 | 4330 | 22 | 22q13 | T | 4330, A5HML1, A9Z1V9, CCDS42998.1, ENSG00000169184, MGCR, MGCR1, MGCR1-PEN, MN1, Q10571, dJ353E16_2 |
| MPL | myeloproliferative leukemia virus oncogene, thrombopoietin receptor | 4352 | 1 | p34 | Mis | 4352, C-MPL, CCDS483.1, CD110, ENSG00000117400, MPL, MPLV, P40238, Q308M1, Q5JUZ0, RP1-92O14_1, TPOR |
| MSF | MLL septin-like fusion | 10801 | 17 | 17q25 | T | 10801, AF17q25, ENSG00000184640, KIAA0991, MSF, MSF1, NAPB, PNUTL4, SEPT9, SINT1, SeptD1 |
| MSH2 | mutS homolog 2 (E. coli) | 4436 | 2 | 2p22-p21 | D, Mis, N, F, S | 4436, CCDS1834.1, COCA1, ENSG00000095002, FCC1, HNPCC, HNPCC1, MSH2, P43246, Q0ZAI9, Q0ZAJ1, Q53FK0, Q53GS1, Q53RU4, Q6VBB7 |
| MSH6 | mutS homolog 6 (E. coli) | 2956 | 2 | 2p16 | Mis, N, F, S | 2956, CCDS1836.1, ENSG00000116062, GTBP, HNPCC5, HSAP, MSH6, P52701, Q1L838, Q3SWU9 |
| MSI2 | musashi homolog 2 (Drosophila) | 124540 | 17 | 17q23.2 | T | 124540, CCDS11597.1, ENSG00000153944, MSI2 |
| MSN | moesin | 4478 | X | Xq11.2-q12 | T | 4478, CCDS14382.1, ENSG00000147065, MSN, P26038, Q6PJT4 |
| MTCP1 | mature T-cell proliferation 1 | 4515 | X | Xq28 | T | 4515, C6_1B, ENSG00000214827, GS1-273L24_4, MTCP1 |
| MUC1 | mucin 1, transmembrane | 4582 | 1 | 1q21 | T | 4582, CCDS1098.1, CD227, EMA, ENSG00000185499, H23AG, MAM6, MUC1, PEM, PEMT, PUM, Q14877, Q4VX39, Q7Z545 |
| MUTYH | mutY homolog (E. coli) | 4595 | 1 | 1p34.3-1p32.1 | Mis | 4595, CCDS520.1, ENSG00000132781, MGC4416, MUTYH, MYH, MYHbeta, hMYH |
| MYB | v-myb myeloblastosis viral oncogene homolog | 4602 | 6 | 6q22-23 | T | 4602, CCDS5174.1, Cmyb, ENSG00000118513, MYB, MYB_ENST00000341911, P10242, Q5THS4, Q5THS5, Q708E1, Q708E3, Q708E4, Q708E5, Q708E7, Q708E9, Q708J0, Q9UMI7, c-myb, c-myb_CDS, efg |
| MYC | v-myc myelocytomatosis viral oncogene homolog (avian) | 4609 | 8 | 8q24.12-q24.13 | A, T | 4609, ENSG00000136997, MYC, c-Myc |
| MYCL1 | v-myc myelocytomatosis viral oncogene homolog 1, lung carcinoma derived (avian) | 4610 | 1 | 1p34.3 | A | 4610, ENSG00000116990, LMYC, MYCL, MYCL1 |
| MYCN | v-myc myelocytomatosis viral related oncogene, neuroblastoma derived (avian) | 4613 | 2 | 2p24.1 | A | 4613, CCDS1687.1, ENSG00000134323, MODED, MYCN, N-myc, NMYC, ODED |
| MYD88 | myeloid differentiation primary response gene (88) | 4615 | 3 | 3p22 | Mis | 4615, B4DKU4, B4DU08, B4E3D6, CCDS2674, MYD88, MYD88D, MYD88_ENST00000396334, Q99836 |
| MYH11 | myosin, heavy polypeptide 11, smooth muscle | 4629 | 16 | 16p13.13-p13.12 | T | 4629, CCDS10566.1, ENSG00000133392, MYH11, O14729, Q16085, Q3MIV8, Q3MNF0, Q4G140, Q68D89, Q7Z7R0 |
| MYH9 | myosin, heavy polypeptide 9, non-muscle | 4627 | 22 | 22q13.1 | T | 4627, CCDS13927.1, DFNA17, ENSG00000100345, MYH9, P35579, Q2PS10, Q60FE2, Q86XU5, Q99529, Q9UMJ0 |
| MYST4 | MYST histone acetyltransferase (monocytic leukemia) 4 (MORF) | 23522 | 10 | 10q22 | T | 23522, CCDS7345.1, DKFZp313G1618, ENSG00000156650, FLJ90335, KIAA0383, MORF, MOZ2, MYST4, Q8WYB5, qkf, querkopf |
| NACA | nascent-polypeptide-associated complex alpha polypeptide | 4666 | 12 | 12q23-q24.1 | T | 4666, CCDS31837.1, ENSG00000196531, FKSG17, HSD48, MGC117224, NACA, NACA1, NACAP1, Q13765, Q9BZK3 |
| NBS1 | Nijmegen breakage syndrome 1 (nibrin) | 4683 | 8 | 8q21 | Mis, N, F | 4683, AT-V1, AT-V2, ATV, CCDS6249.1, ENSG00000104320, FLJ10155, MGC87362, NBN, NBS, NBS1 |
| NCOA1 | nuclear receptor coactivator 1 | 8648 | 2 | 2p23 | T | 8648, CCDS1712.1, ENSG00000084676, F-SRC-1, MGC129719, MGC129720, NCOA1, NCoA-1, RIP160, SRC1 |
| NCOA2 | nuclear receptor coactivator 2 (TIF2) | 10499 | 8 | 8q13.1 | T | 10499, ENSG00000140396, GRIP1, MGC138808, NCOA2, NCoA-2, TIF2 |
| NCOA4 | nuclear receptor coactivator 4 - PTC3 (ELE1) | 8031 | 10 | 10q11.2 | T | 8031, ARA70, CCDS7237.1, DKFZp762E1112, ELE1, ENSG00000138293, NCOA4, PTC3, Q13772, Q5T1E8, RFG, RP11-481A12_4 |
| NDRG1 | N-myc downstream regulated 1 | 10397 | 8 | 8q24.3 | T | 10397, CAP43, CCDS34945.1, CMT4D, DRG1, ENSG00000104419, GC4, HMSNL, NDR1, NDRG1, NMSL, PROXY1, Q53EU7, Q597H1, Q6IBG2, Q92597, Q9BRH7, RIT42, RTP, TARG1, TDD5 |
| NF1 | neurofibromatosis type 1 gene | 4763 | 17 | 17q12 | D, Mis, N, F, S, O | 4763, ENSG00000196712, NF1, NFNS, P21359, Q14931, Q4W6X4, Q7Z3J5, Q9UMU3 |
| NF2 | neurofibromatosis type 2 gene | 4771 | 22 | 22q12.2 | D, Mis, N, F, S, O | 4771, ACN, BANF, CCDS13861.1, ENSG00000186575, Merlin, NF2, P35240, Q9NRW8, SCH |
| NFE2L2 | nuclear factor (erythroid-derived 2)-like 2 (NRF2) | 4780 | 2 | 2q31 | Mis | 4780, CCDS42782.1, ENSG00000116044, NFE2L2, NRF2, Q16236, Q9BZF8 |
| NFIB | nuclear factor I/B | 4781 | 9 | 9p24.1 | T | 4781, CCDS6474.1, ENSG00000147862, NFI-RED, NFIB, NFIB2, NFIB3, NFIB_ENST00000397581, Q5VW26, RP11-280O24_2 |
| NFKB2 | nuclear factor of kappa light polypeptide gene enhancer in B-cells 2 (p49/p100) | 4791 | 10 | 10q24 | T | 4791, A8K9D9, CCDS41565.1, ENSG00000077150, LYT-10, LYT10, NFKB2 |
| NIN | ninein (GSK3B interacting protein) | 51199 | 14 | 14q24 | T | 51199, CCDS32078.1, ENSG00000100503, KIAA1565, NIN |
| NKX2-1 | NK2 homeobox 1 | 7080 | 14 | 14q13 | A | 7080, BCH, BHC, CCDS9659.1, ENSG00000136352, NK-2, NKX2-1, NKX2A, NKX2_1, O14956, P43699, Q7KZF6, TEBP, TITF1, TTF-1, TTF1 |
| NONO | non-POU domain containing, octamer-binding | 4841 | X | Xq13.1 | T | 4841, CCDS14410.1, ENSG00000147140, NMT55, NONO, NRB54, P54, P54NRB, Q15233 |
| NOTCH1 | Notch homolog 1, translocation-associated (Drosophila) (TAN1) | 4851 | 9 | 9q34.3 | T, Mis, O | 4851, ENSG00000148400, NOTCH1, P46531, Q59ED8, Q5SXM3, TAN1, hN1 |
| NOTCH2 | Notch homolog 2 | 4853 | 1 | 1p13-p11 | N, F, Mis | 4853, AGS2, CCDS908.1, ENSG00000134250, NOTCH2, Q04721, Q13560, Q5VTD0, Q6IQ50, Q96JU8, Q9UFD5, hN2 |
| NPM1 | nucleophosmin (nucleolar phosphoprotein B23, numatrin) | 4869 | 5 | 5q35 | T, F | 4869, B23, CCDS4376.1, ENSG00000181163, MGC104254, NPM, NPM1, P06748 |
| NR4A3 | nuclear receptor subfamily 4, group A, member 3 (NOR1) | 8013 | 9 | 9q22 | T | 8013, A2A3I7, CCDS6742.1, CHN, CSMF, ENSG00000119508, MINOR, NOR1, NR4A3, Q92570, TEC |
| NRAS | neuroblastoma RAS viral (v-ras) oncogene homolog | 4893 | 1 | 1p13.2 | Mis | 4893, ENSG00000213281, N-ras, NRAS, NRAS1, P01111 |
| NSD1 | nuclear receptor binding SET domain protein 1 | 64324 | 5 | 5q35 | T | 64324, ARA267, CCDS4412.1, DKFZp666C163, ENSG00000165671, FLJ22263, FLJ44628, NSD1, Q658U6, Q8NB95, Q96DQ7, Q96L73, Q96MN8, Q9H6B5, Q9H6H8, SOTOS, STO |
| NTRK1 | neurotrophic tyrosine kinase, receptor, type 1 | 4914 | 1 | 1q21-q22 | T | 4914, CCDS1161.1, DKFZp781I14186, ENSG00000198400, MTC, NTRK1, P04629, TRK, TRK1, TRKA, p140-TrkA |
| NTRK3 | neurotrophic tyrosine kinase, receptor, type 3 | 4916 | 15 | 15q25 | T | 4916, CCDS10340.1, ENSG00000140538, NTRK3, Q16288, TRKC, gp145(trkC) |
| NUMA1 | nuclear mitotic apparatus protein 1 | 4926 | 11 | 11q13 | T | 4926, CCDS31633.1, ENSG00000137497, NUMA, NUMA1, Q14980, Q3SYK8, Q4LE64, Q86XH4, Q9UNL7, Q9UPG3 |
| NUP214 | nucleoporin 214kDa (CAN) | 8021 | 9 | 9q34.1 | T | 8021, CAIN, CAN, CCDS6940.1, D9S46E, ENSG00000126883, MGC104525, N214, NUP214, P35658, Q3KQZ0, Q5JUP7, Q5JUP9, Q75R47, Q7Z3C4, Q86XD3, RP11-544A12_7 |
| NUP98 | nucleoporin 98kDa | 4928 | 11 | 11p15 | T | 4928, ADIR2, CCDS7746.1, ENSG00000110713, NUP196, NUP98 |
| OLIG2 | oligodendrocyte lineage transcription factor 2 (BHLHB1) | 10215 | 21 | 21q22.11 | T | 10215, BHLHB1, CCDS13620.1, ENSG00000205927, OLIG2, OLIGO2, PRKCBP2, RACK17 |
| OMD | osteomodulin | 4958 | 9 | 9q22.31 | T | 4958, CCDS6696.1, ENSG00000127083, OMD, Q5TBF4, Q99983, SLRR2C, osteoadherin |
| P2RY8 | purinergic receptor P2Y, G-protein coupled, 8 | 286530 | X,Y | Xp22.3; Yp11.3 | T | 286530, CCDS14115.1, ENSG00000182162, MGC50878, P2RY8, P2Y8, Q86VZ1, RP11-261P4_4 |
| PAFAH1B2 | platelet-activating factor acetylhydrolase, isoform Ib, beta subunit 30kDa | 5049 | 11 | 11q23 | T | 5049, CCDS8380.1, ENSG00000168092, P68402, PAFAH1B2, Q6IBR6 |
| PALB2 | partner and localizer of BRCA2 | 79728 | 16 | 16p12.1 | F, N, Mis | 79728, ENSG00000083093, PALB2 |
| PAX3 | paired box gene 3 | 5077 | 2 | 2q35 | T | 5077, CCDS2448.1, CDHS, ENSG00000135903, HUP2, MGC120381, MGC120382, MGC120383, MGC120384, MGC134778, P23760, PAX3, Q12777, Q494Z3, Q494Z4, WS1 |
| PAX5 | paired box gene 5 (B-cell lineage specific activator protein) | 5079 | 9 | 9p13 | T, Mis, D, F, S | 5079, BSAP, CCDS6607.1, ENSG00000196092, PAX5, Q02548, Q5VVI9 |
| PAX7 | paired box gene 7 | 5081 | 1 | 1p36.2-p36.12 | T | 5081, CCDS186.1, ENSG00000009709, HUP1, P23759, PAX7, PAX7B, Q0VA99, Q2PJS5 |
| PAX8 | paired box gene 8 | 7849 | 2 | 2q12-q14 | T | 7849, ENSG00000125618, PAX8 |
| PBRM1 | polybromo 1 | 55193 | 3 | 3p21 | Mis, N, F, S, D, O | 55193, BAF180, C9J053, C9J409, C9J9L6, C9JCJ2, C9JPI5, C9JQF1, CCDS2860, MGC156155, MGC156156, PB1, PBRM1, Q6IRX1, Q9NUX9 |
| PBX1 | pre-B-cell leukemia transcription factor 1 | 5087 | 1 | 1q23 | T | 5087, CCDS1246.1, P40424, PBX1, Q5T487, Q68DD6 |
| PCM1 | pericentriolar material 1 (PTC4) | 5108 | 8 | 8p22-p21.3 | T | 5108, B4DWY1, B4DYD5, ENSG00000078674, PCM1, PTC4, Q15154 |
| PCSK7 | proprotein convertase subtilisin/kexin type 7 | 9159 | 11 | 11q23.3 | T | 9159, CCDS8382.1, ENSG00000160613, LPC, PC7, PC8, PCSK7, Q16549, Q3C1X1, Q53GM4, Q6PK65, Q96FK8, SPC7 |
| PDE4DIP | phosphodiesterase 4D interacting protein (myomegalin) | 9659 | 1 | 1q12 | T | 9659, CCDS30824.1, ENSG00000178104, PDE4DIP, Q5VU42, Q5VU43, Q5VU47, Q68DU2, Q86T40, Q8N3W0, Q9HCP3, Q9HCP4, Q9HCP5 |
| PDGFB | platelet-derived growth factor beta polypeptide (simian sarcoma viral (v-sis) oncogene homolog) | 5155 | 22 | 22q12.3-q13.1 | T | 5155, A2NWD3, CCDS13987.1, ENSG00000100311, FLJ12858, P01127, P78450, PDGF2, PDGFB, Q6FHE7, Q9UE56, Q9UE57, SIS, SSV, c-sis |
| PDGFRA | platelet-derived growth factor, alpha-receptor | 5156 | 4 | 4q11-q13 | Mis, O, T | 5156, CCDS3495.1, CD140A, CD140a, ENSG00000134853, MGC74795, P16234, PDGFR2, PDGFRA, Rhe-PDGFRA |
| PDGFRB | platelet-derived growth factor receptor, beta polypeptide | 5159 | 5 | 5q31-q32 | T | 5159, CCDS4303.1, CD140B, CD140b, ENSG00000113721, JTK12, P09619, PDGF-R-beta, PDGFR, PDGFR1, PDGFRB |
| PER1 | period homolog 1 (Drosophila) | 5187 | 17 | 17p13.1-17p12 | T | 5187, A2I2P6, CCDS11131.1, ENSG00000179094, O15534, PER, PER1, Q6IN51, Q8N6U1, Q9H2D0, RIGUI |
| PHF6 | PHD finger protein 6 | 84295 | X | Xq26.3 | F, N, Splice, Mis | 84295, BORJ, ENSG00000156531, MGC14797, PHF6 |
| PHOX2B | paired-like homeobox 2b | 8929 | 4 | 4p12 | Mis, F | 8929, PHOX2B |
| PICALM | phosphatidylinositol binding clathrin assembly protein (CALM) | 8301 | 11 | 11q14 | T | 8301, CALM, CCDS8272.1, CLTH, ENSG00000073921, PICALM, Q13492, Q4LE54 |
| PIK3CA | phosphoinositide-3-kinase, catalytic, alpha polypeptide | 5290 | 3 | 3q26.3 | Mis | 5290, ENSG00000121879, MGC142161, MGC142163, P42336, PI3K, PIK3CA, p110-alpha |
| PIK3R1 | phosphoinositide-3-kinase, regulatory subunit 1 (alpha) | 5295 | 5 | 5q13.1 | Mis, F, O | 5295, CCDS3993.1, CCDS3995.1, ENSG00000145675, GRB1, P27986, PIK3R1, p85-ALPHA |
| PIM1 | pim-1 oncogene | 5292 | 6 | 6p21.2 | T | 5292, ENSG00000137193, P11309, PIM, PIM1 |
| PLAG1 | pleiomorphic adenoma gene 1 | 5324 | 8 | 8q12 | T | 5324, CCDS6165.1, ENSG00000181690, PLAG1, Q59GH8, Q6DJT9, Q9Y4L2 |
| PML | promyelocytic leukemia | 5371 | 15 | 15q22 | T | 5371, CCDS10255.1, ENSG00000140464, MYL, PML, PP8675, RNF71, TRIM19 |
| PMS1 | PMS1 postmeiotic segregation increased 1 (S. cerevisiae) | 5378 | 2 | 2q31-q33 | Mis, N | 5378, CCDS2302.1, DKFZp781M0253, ENSG00000064933, HNPCC3, PMS1, PMSL1, hPMS1 |
| PMS2 | PMS2 postmeiotic segregation increased 2 (S. cerevisiae) | 5395 | 7 | 7p22 | Mis, N, F | 5395, CCDS5343.1, ENSG00000122512, HNPCC4, H_DJ0042M02_9, PMS2, PMS2CL, PMSL2 |
| PMX1 | paired mesoderm homeo box 1 | 5396 | 1 | 1q24 | T | 5396, CCDS1291.1, ENSG00000116132, PMX1, PRRX1 |
| PNUTL1 | peanut-like 1 (Drosophila) | 5413 | 22 | 22q11.2 | T | 5413, CCDS13764.1, ENSG00000184702, H5, HCDCREL-1, O95648, PNUTL1, Q99719, SEPT5 |
| POU2AF1 | POU domain, class 2, associating factor 1 (OBF1) | 5450 | 11 | 11q23.1 | T | 5450, BOB1, CCDS31675.1, ENSG00000110777, OBF-1, OBF1, OCAB, POU2AF1, Q16633 |
| POU5F1 | POU domain, class 5, transcription factor 1 | 5460 | 6 | 6p21.31 | T | 5460, ENSG00000230336, MGC22487, OCT3, OCT4, OTF3, OTF3C, OTF3P1, OTF4, Oct4, POU5F1, POU5F1P1 |
| PPARG | peroxisome proliferative activated receptor, gamma | 5468 | 3 | 3p25 | T | 5468, CCDS2609.1, ENSG00000132170, HUMPPARG, NR1C3, PPARG, PPARG1, PPARG2 |
| PPP2R1A | protein phosphatase 2, regulatory subunit A, alpha | 5518 | 19 | 19q13.41 | Mis | 5518, CCDS12849.1, ENSG00000105568, MGC786, P30153, PPP2R1A, PR65A, Q6ICQ3, Q96DH3 |
| PRCC | papillary renal cell carcinoma (translocation-associated) | 5546 | 1 | 1q21.1 | T | 5546, CCDS1157, CCDS1158.1, ENSG00000143294, MGC17178, MGC4723, PRCC, PRCC_ENST00000353233, Q5SZ06, Q92733, Q96FT4, RCCP1, TPRC |
| PRDM1 | PR domain containing 1, with ZNF domain | 639 | 6 | 6q21 | D, N, Mis, F, S | 639, BLIMP1, CCDS5054, ENSG00000057657, MGC118922, MGC118923, MGC118924, MGC118925, O75626, PRDI-BF1, PRDM1, Q5T4E8, Q658W0, RP1-134E15_1 |
| PRDM16 | PR domain containing 16 | 63976 | 1 | 1p36.23-p33 | T | 63976, ENSG00000142611, KIAA1675, MEL1, PFM13, PRDM16, Q5VU54, Q9HAZ2 |
| PRF1 | perforin 1 (pore forming protein) | 5551 | 10 | 10q22 | M | 5551, CCDS7305.1, ENSG00000180644, FLH2, HPLH2, MGC65093, P1, P14222, PFP, PRF1, Q59F57 |
| PRKAR1A | protein kinase, cAMP-dependent, regulatory, type I, alpha (tissue specific extinguisher 1) | 5573 | 17 | 17q23-q24 | T, Mis, N, F, S | 5573, CAR, CCDS11678.1, CNC, CNC1, DKFZp779L0468, ENSG00000108946, MGC17251, P10644, PKR1, PPNAD1, PRKAR1, PRKAR1A, Q68DQ4, Q96P62, TSE1 |
| PRO1073 | PRO1073 protein (ALPHA) | 29005 | 11 | 11q31.1 | T | 29005, PRO1073, Q9UHZ2 |
| PSIP2 | PC4 and SFRS1 interacting protein 2 (LEDGF) | 11168 | 9 | 9p22.2 | T | 11168, CCDS6480.1, ENSG00000164985, PSIP1, PSIP2, Q05CM9, Q8N4N4 |
| PTCH | Homolog of Drosophila Patched gene | 5727 | 9 | 9q22.3 | Mis, N, F, S | 5727, BCNS, CCDS6714.1, ENSG00000185920, FLJ26746, FLJ42602, HPE7, NBCCS, PTC, PTC1, PTCH, PTCH1, Q13635, Q59FG5, Q5R1U7, Q5R1V0, Q5VZC2, Q6TKP8, Q6TKP9, Q6TKQ0, Q86XG7, RP11-435O5_3 |
| PTEN | phosphatase and tensin homolog gene | 5728 | 10 | 10q23.3 | D, Mis, N, F, S | 5728, BZS, ENSG00000171862, MGC11227, MHAM, MMAC1, P60484, PTEN, PTEN1, TEP1 |
| PTPN11 | protein tyrosine phosphatase, non-receptor type 11 | 5781 | 12 | 12q24.1 | Mis | 5781, BPTP3, CCDS9163.1, CFC, ENSG00000179295, MGC14433, NS1, PTP-1D, PTP2C, PTPN11, Q06124, Q16344, SH-PTP2, SH-PTP3, SHP-2, SHP2 |
| RAB5EP | rabaptin, RAB GTPase binding effector protein 1 (RABPT5) | 9135 | 17 | 17p13 | T | 9135, ENSG00000029725, Q05BX6, Q15276, RAB5EP, RABEP1, RABPT5, neurocrescin, rabaptin-5 |
| RAD51L1 | RAD51-like 1 (S. cerevisiae) (RAD51B) | 5890 | 14 | 14q23-q24.2 | T | 5890, CCDS9789.1, ENSG00000182185, MGC34245, O15315, R51H2, RAD51B, RAD51L1, REC2, hREC2 |
| RAF1 | v-raf-1 murine leukemia viral oncogene homolog 1 | 5894 | 3 | 3p25 | T | 5894, CCDS2612.1, CRAF, ENSG00000132155, P04049, RAF1, Raf-1, c-Raf |
| RALGDS | ral guanine nucleotide dissociation stimulator | 5900 | 9 | 9q34.3 | T | 5900, CCDS6959.1, ENSG00000160271, FLJ20922, Q12967, Q5T7V4, Q6ZSD5, Q8N4Y1, Q8NF31, Q8WU11, Q9HAX8, Q9HAX9, Q9HAY0, RALGDS, RGF, RalGEF |
| RANBP17 | RAN binding protein 17 | 64901 | 5 | 5q34 | T | 64901, CCDS34287.1, ENSG00000204764, FLJ32916, Q546R4, Q8IU74, Q8IVM9, Q96M10, Q9H2T7, RANBP17 |
| RAP1GDS1 | RAP1, GTP-GDP dissociation stimulator 1 | 5910 | 4 | 4q21-q25 | T | 5910, ENSG00000138698, GDS1, MGC118859, MGC118861, P52306, Q4QQI8, Q9BUX6, RAP1GDS1 |
| RARA | retinoic acid receptor, alpha | 5914 | 17 | 17q12 | T | 5914, CCDS11366.1, ENSG00000131759, NR1B1, RAR, RARA |
| RB1 | retinoblastoma gene | 5925 | 13 | 13q14 | D, Mis, N, F, S | 5925, ENSG00000139687, OSRC, P06400, RB, RB1 |
| RBM15 | RNA binding motif protein 15 | 64783 | 1 | 1p13 | T | 64783, A1A693, CCDS822.1, ENSG00000162775, OTT, OTT1, Q59EY1, Q96T37, RBM15 |
| RECQL4 | RecQ protein-like 4 | 9401 | 8 | 8q24.3 | N, F, S | 9401, ENSG00000160957, RECQ4, RECQL4, RTS, RecQ4 |
| REL | v-rel reticuloendotheliosis viral oncogene homolog (avian) | 5966 | 2 | 2p13-p12 | A | 5966, C-Rel, CCDS1864.1, ENSG00000162924, I-Rel, REL |
| RET | ret proto-oncogene | 5979 | 10 | 10q11.2 | T, Mis, N, F | 5979, CCDS7200.1, CDHF12, ENSG00000165731, HSCR1, MEN2A, MEN2B, MTC1, P07949, PTC, RET, RET-ELE1, RET51 |
| ROS1 | v-ros UR2 sarcoma virus oncogene homolog 1 (avian) | 6098 | 6 | 6q22 | T | 6098, ENSG00000047936, MCF3, P08922, ROS, ROS1, RP1-179P9_1 |
| RPL22 | ribosomal protein L22 (EAP) | 6146 | 1 | 1p36.31 | T | 6146, CCDS58.1, EAP, RPL22 |
| RPN1 | ribophorin I | 6184 | 3 | 3q21.3-q25.2 | T | 6184, CCDS3051.1, ENSG00000163902, OST1, P04843, Q53EP4, Q68DT1, Q6IBR0, Q96HX3, RPN1 |
| RUNDC2A | RUN domain containing 2A | 84127 | 16 | 16p13.13 | T | 84127, CCDS10553.1, ENSG00000140660, FLJ12363, Q9HA26, RUNDC2A |
| RUNX1 | runt-related transcription factor 1 (AML1) | 861 | 21 | 21q22.3 | T | 861, AML1, AMLCR1, CBFA2, CCDS13639.1, ENSG00000159216, PEBP2A2, Q01196, RUNX1 |
| RUNXBP2 | runt-related transcription factor binding protein 2 (MOZ/ZNF220) | 7994 | 8 | 8p11 | T | 7994, CCDS6124.1, ENSG00000083168, MOZ, MYST3, Q92794, RUNXBP2, ZNF220 |
| SBDS | Shwachman-Bodian-Diamond syndrome protein | 51119 | 7 | 7q11 | Gene Conversion | 51119, CCDS5537.1, CGI-97, ENSG00000126524, FLJ10917, Q9Y3A5, SBDS, SDS, SWDS |
| SDC4 | syndecan 4 | 6385 | 20 | 20q12 | T | 6385, CCDS13350.1, ENSG00000124145, MGC22217, P31431, Q53FN9, Q6FGN3, SDC4, SYND4 |
| SDH5 | chromosome 11 open reading frame 79 | 54949 | 11 | 11q12.2 | M | 54949, C11orf79, CCDS8007.1, ENSG00000167985, FLJ20487, Q9NX18, SDH5, SDHAF2 |
| SDHB | succinate dehydrogenase complex, subunit B, iron sulfur (Ip) | 6390 | 1 | 1p36.1-p35 | Mis, N, F | 6390, CCDS176.1, ENSG00000117118, IP, PGL4, SDH, SDH1, SDHB, SDHIP |
| SDHC | succinate dehydrogenase complex, subunit C, integral membrane protein, 15kDa | 6391 | 1 | 1q21 | Mis, N, F | 6391, CYB560, CYBL, ENSG00000143252, PGL3, QPS1, SDH3, SDHC |
| SDHD | succinate dehydrogenase complex, subunit D, integral membrane protein | 6392 | 11 | 11q23 | Mis, N, F, S | 6392, CBT1, CCDS31678.1, ENSG00000204370, O14521, PGL, PGL1, Q53XW5, SDH4, SDHD |
| SEPT6 | septin 6 | 23157 | X | Xq24 | T | 23157, CCDS14584.1, ENSG00000125354, KIAA0128, MGC16619, MGC20339, Q14141, Q5JTK3, Q6B514, Q6NT82, Q8NFH9, RP5-876A24_2, SEP2, SEPT2, SEPT6 |
| SET | SET translocation | 6418 | 9 | 9q34 | T | 2PP2A, 6418, CCDS6907.1, ENSG00000119335, ENSG00000181555, I2PP2A, IGAAD, PHAPII, SET, SETD2, SETD2_ENST00000409792, TAF-IBETA |
| SETD2 | SET domain containing 2 | 29072 | 3 | 3p21.31 | N, F, S, Mis | 29072, ENSG00000181555, SETD2 |
| SF3B1 | splicing factor 3b, subunit 1, 155kDa | 23451 | 2 | 2q33.1 | Mis | 23451, A0JLT9, A0PJH5, CCDS33356.1, ENSG00000115524, O75533, PRP10, PRPF10, Q32Q20, Q7Z497, Q9NTB4, SAP155, SF3B1, SF3b155 |
| SFPQ | splicing factor proline/glutamine rich(polypyrimidine tract binding protein associated) | 6421 | 1 | 1p34.3 | T | 6421, CCDS388.1, ENSG00000116560, P23246, PSF, Q5SZ71, Q6PIX2, Q86VG2, Q9BSV4, SFPQ |
| SFRS3 | splicing factor, arginine/serine-rich 3 | 6428 | 6 | 6p21 | T | 6428, CCDS4823.1, ENSG00000112081, P84103, Q5R3K0, SFRS3, SRSF3, SRp20 |
| SH3GL1 | SH3-domain GRB2-like 1 (EEN) | 6455 | 19 | 19p13.3 | T | 6455, CCDS32874.1, CNSA1, EEN, ENSG00000141985, Q6FGM0, Q99961, Q9BVL7, Q9BWP4, Q9UQD4, SH3D2B, SH3GL1, SH3P8 |
| SIL | TAL1 (SCL) interrupting locus | 6491 | 1 | 1p32 | T | 6491, CCDS548.1, ENSG00000123473, Q15468, Q5T0C6, Q5T0C9, Q5T0D0, SIL, STIL |
| SLC34A2 | solute carrier family 34 (sodium phosphate), member 2 | 10568 | 4 | 4p15.2 | T | 10568, CCDS3435.1, ENSG00000157765, FLJ90534, NAPI-3B, NAPI-IIb, NPTIIb, O95436, SLC34A2 |
| SLC45A3 | solute carrier family 45, member 3 | 85414 | 1 | 1q32 | T | 85414, CCDS1458.1, ENSG00000158715, IPCA-6, IPCA6, PCANAP6, PRST, Q658X7, Q96JT2, SLC45A3 |
| SMARCA4 | SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 4 | 6597 | 19 | 19p13.2 | F, N, Mis | 6597, BAF190, BRG1, CCDS12253.1, ENSG00000127616, FLJ39786, P51532, Q59FZ6, SMARCA4, SNF2, SNF2-BETA, SNF2L4, SNF2LB, SWI2, hSNF2b |
| SMARCB1 | SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily b, member 1 | 6598 | 22 | 22q11 | D, N, F, S | 6598, BAF47, CCDS13817.1, ENSG00000099956, INI1, Ini1, Q12824, RDT, SMARCB1, SNF5, SNF5L1, Sfh1p, Snr1, hSNFS |
| SMO | smoothened homolog (Drosophila) | 6608 | 7 | 7q31-q32 | Mis | 6608, CCDS5811.1, ENSG00000128602, Gx, NP_005622, Q99835, Q9Y2Y5, SMO, SMOH |
| SOCS1 | suppressor of cytokine signaling 1? | 8651 | 16 | 16p13.13 | F, O | 8651, CCDS10546.1, CIS1, CISH1, Cish1, ENSG00000185338, JAB, O15524, Q4JHT5, SOCS-1, SOCS1, SSI-1, SSI1, TIP3 |
| SOX2 | SRY (sex determining region Y)-box 2 | 6657 | 3 | 3q26.3-q27 | A | 6657, ANOP3, CCDS3239.1, ENSG00000181449, MCOPS3, MGC2413, P48431, Q9UD89, SOX2 |
| SRGAP3 | SLIT-ROBO Rho GTPase activating protein 3 | 9901 | 3 | 3p25.3 | T | 9901, ARHGAP14, CCDS2572.1, ENSG00000196220, KIAA0411, MEGAP, SRGAP2, SRGAP3, WRP |
| SRSF2 | serine/arginine-rich splicing factor 2 | 6427 | 17 | 17q25 | Mis | 6427, CCDS11749.1, Q01130, Q53FN0, SFRS2, SRSF2 |
| SS18 | synovial sarcoma translocation, chromosome 18 | 6760 | 18 | 18q11.2 | T | 6760, CCDS32807.1, ENSG00000141380, Q15532, Q4VAX2, Q8TDQ9, SS18, SSXT, SYT |
| SS18L1 | synovial sarcoma translocation gene on chromosome 18-like 1 | 26039 | 20 | 20q13.3 | T | 26039, CCDS13491.1, ENSG00000184402, KIAA0693, O75177, Q6MZV9, Q6XYD9, SS18L1 |
| SSH3BP1 | spectrin SH3 domain binding protein 1 | 10006 | 10 | 10p11.2 | T | 10006, ABI-1, ABI1, CCDS7150.1, E3B1, SSH3BP1 |
| SSX1 | synovial sarcoma, X breakpoint 1 | 6756 | X | Xp11.23-p11.22 | T | 6756, CCDS14290.1, ENSG00000126752, MGC150425, MGC5162, Q16384, RP11-552E4_1, SSRC, SSX1 |
| SSX2 | synovial sarcoma, X breakpoint 2 | 6757 | X | Xp11.23-p11.22 | T | 6757, CCDS14345.1, ENSG00000157950, HD21, HOM-MEL-40, MGC119055, MGC15364, MGC3884, Q8WWZ9, Q9NZK4, RP11-552J9_2, SSX, SSX2 |
| SSX4 | synovial sarcoma, X breakpoint 4 | 6759 | X | Xp11.23 | T | 6759, CCDS35240.1, ENSG00000204645, MGC119056, MGC12411, O60224, SSX4 |
| STK11 | serine/threonine kinase 11 gene (LKB1) | 6794 | 19 | 19p13.3 | D, Mis, N, F, S | 6794, ENSG00000118046, LKB1, PJS, Q15831, STK11 |
| STL | Six-twelve leukemia gene | 7955 | 6 | 6q23 | T | |
| SUFU | suppressor of fused homolog (Drosophila) | 51684 | 10 | 10q24.32 | D, F, S | 51684, CCDS7537.1, ENSG00000121410, PRO1280, Q5JSM1, Q5JWB5, Q9UMX1, RP11-47A8_1, SUFU, SUFUH, SUFUXL |
| SUZ12 | suppressor of zeste 12 homolog (Drosophila) | 23512 | 17 | 17q11.2 | T | 23512, CCDS11270.1, CHET9, ENSG00000178691, JJAZ1, KIAA0160, Q15022, SUZ12 |
| SYK | spleen tyrosine kinase | 6850 | 9 | 9q22 | T | 6850, CCDS6688.1, ENSG00000165025, P43405, SYK |
| TAF15 | TAF15 RNA polymerase II, TATA box binding protein (TBP)-associated factor, 68kDa | 8148 | 17 | 17q11.1-q11.2 | T | 8148, CCDS32623.1, ENSG00000172660, Npl3, Q86X94, Q92804, RBP56, TAF15, TAF2N, hTAFII68 |
| TAL1 | T-cell acute lymphocytic leukemia 1 (SCL) | 6886 | 1 | 1p32 | T | 6886, CCDS547.1, ENSG00000162367, P17542, Q16509, Q9UE36, SCL, TAL1, TCL5, tal-1 |
| TAL2 | T-cell acute lymphocytic leukemia 2 | 6887 | 9 | 9q31 | T | 6887, CCDS6767.1, Q16559, TAL2 |
| TCEA1 | transcription elongation factor A (SII), 1 | 6917 | 8 | 8q11.2 | T | 6917, ENSG00000187735, TCEA1 |
| TCF1 | transcription factor 1, hepatic (HNF1) | 6927 | 12 | 12q24.2 | Mis, F | 6927, CCDS9209.1, ENSG00000135100, HNF1, HNF1A, LFB1, MODY3, P20823, TCF1 |
| TCF12 | transcription factor 12 (HTF4, helix-loop-helix transcription factors 4) | 6938 | 15 | 15q21 | T | 6938, CCDS10160.1, ENSG00000140262, HEB, HTF4, HsT17266, Q86VM2, Q9NQY1, Q9NQY2, Q9NQY3, Q9NQY4, Q9NQY5, Q9NQY6, Q9NQY7, Q9NQY9, TCF12 |
| TCF3 | transcription factor 3 (E2A immunoglobulin enhancer binding factors E12/E47) | 6929 | 19 | 19p13.3 | T | 6929, CCDS12074.1, E2A, ENSG00000071564, ITF1, MGC129647, MGC129648, P15923, Q6PJU3, TCF3 |
| TCF7L2 | transcription factor 7-like 2 | 6934 | 10 | 10q25.3 | T | 6934, CCDS7576.1, ENSG00000148737, Q6FHW4, TCF-4, TCF4, TCF7L2 |
| TCL1A | T-cell leukemia/lymphoma 1A | 8115 | 14 | 14q32.1 | T | 8115, CCDS9941.1, ENSG00000100721, P56279, TCL1, TCL1A |
| TCL6 | T-cell leukemia/lymphoma 6 | 27004 | 14 | 14q32.1 | T | 27004, CCDS9940.1, ENSG00000187621, P56847, Q9NPH1, TCL6 |
| TET2 | tet oncogene family member 2 | 54790 | 4 | 4q24 | Mis N, F | 54790, A7E237, B5MDU0, C3W8F4, ENSG00000168769, FLJ20032, KIAA1546, MGC125715, Q6N021, TET2, TET2-202 |
| TFE3 | transcription factor binding to IGHM enhancer 3 | 7030 | X | Xp11.22 | T | 7030, CCDS14315.2, ENSG00000068323, RCCP2, TFE3, TFEA |
| TFEB | transcription factor EB | 7942 | 6 | 6p21 | T | 7942, AlphaTFEB, CCDS4858.1, ENSG00000112561, P19484, Q4VXW8, Q4VXX0, Q5QPI1, Q5QPI2, Q709A5, Q709A8, Q709A9, Q86WB1, TCFEB, TFEB |
| TFG | TRK-fused gene | 10342 | 3 | 3q11-q12 | T | 10342, CCDS2939.1, ENSG00000114354, Q7Z426, Q7Z427, Q92734, Q969I2, TF6, TFG |
| TFPT | TCF3 (E2A) fusion partner (in childhood Leukemia) | 29844 | 19 | 19q13 | T | 29844, CCDS12878.1, ENSG00000105619, P0C1Z6, TFPT |
| TFRC | transferrin receptor (p90, CD71) | 7037 | 3 | 3q29 | T | 7037, CCDS3312.1, CD71, ENSG00000072274, P02786, Q1HE24, TFR1, TFRC |
| THRAP3 | thyroid hormone receptor associated protein 3 (TRAP150) | 9967 | 1 | 1p34.3 | T | 9967, CCDS405.1, ENSG00000054118, FLJ22082, MGC133082, MGC133083, Q05D20, Q6P0P7, Q6PJV4, Q7Z5U1, Q9Y2W1, THRAP3, TRAP150 |
| TIF1 | transcriptional intermediary factor 1 (PTC6,TIF1A) | 8805 | 7 | 7q32-q34 | T | 8805, CCDS5847.1, ENSG00000122779, P04720, PTC6, RNF82, TF1A, TIF1, TIF1A, TIF1ALPHA, TRIM24, Tif1a, hTIF1 |
| TLX1 | T-cell leukemia, homeobox 1 (HOX11) | 3195 | 10 | 10q24 | T | 3195, A1L4G3, CCDS7510.1, ENSG00000107807, HOX11, P31314, Q5VXP2, Q9UD59, TCL3, TLX1 |
| TLX3 | T-cell leukemia, homeobox 3 (HOX11L2) | 30012 | 5 | 5q35.1 | T | 30012, CCDS34288.1, ENSG00000164438, HOX11L2, O43711, RNX, TLX3 |
| TMPRSS2 | transmembrane protease, serine 2 | 7113 | 21 | 21q22.3 | T | 7113, CCDS33564.1, ENSG00000184012, O15393, PRSS10, Q96T73, TMPRSS2 |
| TNFAIP3 | tumor necrosis factor, alpha-induced protein 3 | 7128 | 6 | 6q23 | D, N, F | 7128, A20, CCDS5187.1, ENSG00000118503, MGC104522, MGC138687, MGC138688, OTUD7C, P21580, Q5PY18, Q5VXQ8, Q5VXQ9, Q5VXR0, TNFA1P2, TNFAIP3 |
| TNFRSF14 | tumor necrosis factor receptor superfamily, member 14 (herpesvirus entry mediator) | 8764 | 1 | 1p36.32 | Mis, N, F | 8764, ATAR, CCDS43.1, ENSG00000157873, HVEA, HVEM, LIGHTR, Q6IB95, Q8N634, Q92956, TNFRSF14, TR2 |
| TNFRSF17 | tumor necrosis factor receptor superfamily, member 17 | 608 | 16 | 16p13.1 | T | 608, BCM, BCMA, CCDS10552.1, CD269, ENSG00000048462, Q02223, Q6PE46, TNFRSF17 |
| TNFRSF6 | tumor necrosis factor receptor superfamily, member 6 (FAS) | 355 | 10 | 10q24.1 | Mis | 355, ALPS1A, APO-1, APT1, CCDS7393.1, CD95, ENSG00000026103, FAS, FAS1, FASTM, P25445, Q5T9P1, Q6ICT6, Q8IUB6, Q8IUB7, TNFRSF6 |
| TOP1 | topoisomerase (DNA) I | 7150 | 20 | 20q12-q13.1 | T | 7150, CCDS13312.1, ENSG00000198900, P11387, Q6NWZ5, Q6PK95, Q9BVT2, RP3-511B24_2, TOP1, TOPI |
| TP53 | tumor protein p53 | 7157 | 17 | 17p13 | Mis, N, F | 7157, CCDS11118.1, ENSG00000141510, LFS1, P04637, P53, TP53, TRP53, p53 |
| TPM3 | tropomyosin 3 | 7170 | 1 | 1q22-q23 | T | 7170, CCDS1060.1, ENSG00000143549, TPM3 |
| TPM4 | tropomyosin 4 | 7171 | 19 | 19p13.1 | T | 7171, CCDS12338.1, ENSG00000167460, P67936, Q5U0D9, TPM4 |
| TPR | translocated promoter region | 7175 | 1 | 1q25 | T | 7175, A0PJC9, P12270, TPR |
| TRA@ | T cell receptor alpha locus | 6955 | 14 | 14q11.2 | T | |
| TRB@ | T cell receptor beta locus | 6957 | 7 | 7q35 | T | |
| TRD@ | T cell receptor delta locus | 6964 | 14 | 14q11 | T | |
| TRIM27 | tripartite motif-containing 27 | 5987 | 6 | 6p22 | T | 5987, CCDS4654.1, DASS-46L4_6, ENSG00000234495, RFP, RNF76, TRIM27 |
| TRIM33 | tripartite motif-containing 33 (PTC7,TIF1G) | 51592 | 1 | 1p13 | T | 51592, ENSG00000197323, FLJ32925, PTC7, Q9UPN9, RFG7, TF1G, TIF1G, TIF1GAMMA, TIFGAMMA, TRIM33 |
| TRIP11 | thyroid hormone receptor interactor 11 | 9321 | 14 | 14q31-q32 | T | 9321, CCDS9899.1, CEV14, ENSG00000100815, Q15643, Q6MZL5, TRIP11, Trip230 |
| TSC1 | tuberous sclerosis 1 gene | 7248 | 9 | 9q34 | D, Mis, N, F, S | 7248, ENSG00000165699, KIAA0243, LAM, MGC86987, TSC, TSC1, hamartin |
| TSC2 | tuberous sclerosis 2 gene | 7249 | 16 | 16p13.3 | D, Mis, N, F, S | 7249, CCDS10458.1, ENSG00000103197, FLJ43106, LAM, TSC2, TSC4, tuberin |
| TSHR | thyroid stimulating hormone receptor | 7253 | 14 | 14q31 | Mis | 7253, CCDS9872.1, ENSG00000165409, LGR3, MGC75129, TSHR, hTSHR-I |
| TTL | tubulin tyrosine ligase | 150465 | 2 | 2q13 | T | 150465, 2410003M22Rik, 284076, CCDS2096.1, ENSG00000114999, ENSG00000170703, FLJ35808, MGC46235, Q585T3, Q8N841, Q8NG68, TTL, TTLL6_ENST00000393382, TTL_6 |
| U2AF1 | U2 small nuclear RNA auxiliary factor 1 | 7307 | 21 | 21q22.3 | Mis | 7307, CCDS13694.1, DKFZp313J1712, ENSG00000160201, FP793, Q01081, Q71RF1, Q7Z780, RN, RNU2AF1, U2AF1, U2AF35, U2AFBP |
| USP6 | ubiquitin specific peptidase 6 (Tre-2 oncogene) | 9098 | 17 | 17p13 | T | 9098, ENSG00000129204, HRP1, TRE17, TRE2, Tre-2, USP6 |
| VHL | von Hippel-Lindau syndrome gene | 7428 | 3 | 3p25 | D, Mis, N, F, S | 7428, A0PJF6, CCDS2597.1, ENSG00000134086, HRCA1, P40337, RCA1, VHL, VHL1 |
| VTI1A | vesicle transport through interaction with t-SNAREs homolog 1A | 143187 | 10 | 10q25.2 | T | 143187, CCDS7575.2, ENSG00000151532, MVti1, Q5W0D7, VTI1A, Vti1-rp2 |
| WAS | Wiskott-Aldrich syndrome | 7454 | X | Xp11.23-p11.22 | Mis, N, F, S | 7454, CCDS14303.1, ENSG00000015285, IMD2, P42768, THC, WAS, WASP |
| WHSC1 | Wolf-Hirschhorn syndrome candidate 1(MMSET) | 7468 | 4 | 4p16.3 | T | 7468, B3VCH6, CCDS33940, D3DVQ2, FLJ23286, KIAA1090, MGC176638, MMSET, NSD2, O96028, REIIBP, TRX5, WHS, WHSC1, WHSC1_ENST00000382891 |
| WHSC1L1 | Wolf-Hirschhorn syndrome candidate 1-like 1 (NSD3) | 54904 | 8 | 8p12 | T | 54904, CCDS6105.1, ENSG00000147548, WHSC1L1 |
| WIF1 | WNT inhibitory factor 1 | 11197 | 12 | 12q14.3 | T | 11197, CCDS8971.1, ENSG00000156076, WIF-1, WIF1 |
| WRN | Werner syndrome (RECQL2) | 7486 | 8 | 8p12-p11.2 | Mis, N, F, S | 7486, A1KYY9, CCDS6082.1, ENSG00000165392, Q14191, Q59F09, RECQ3, RECQL2, WRN |
| WT1 | Wilms tumour 1 gene | 7490 | 11 | 11p13 | D, Mis, N, F, S | 7490, ENSG00000184937, GUD, WAGR, WIT-2, WT1, WT33 |
| WTX | family with sequence similarity 123B (FAM123B) | 139285 | X | Xq11.1 | F, D, N, Mis | 139285, CCDS14377.1, ENSG00000184675, FAM123B, FLJ39827, RP11-403E24_2, WTX |
| WWTR1 | WW domain containing transcription regulator 1 | 607392 | 3 | 3q23-q24 | T | 25937, CCDS3144.1, DKFZP586I1419, ENSG00000018408, Q9GZV5, TAZ, WWTR1 |
| XPA | xeroderma pigmentosum, complementation group A | 7507 | 9 | 9q22.3 | Mis, N, F, S | 7507, CCDS6729.1, ENSG00000136936, P23025, Q5T1U9, Q6LD02, XP1, XPA, XPAC |
| XPC | xeroderma pigmentosum, complementation group C | 7508 | 3 | 3p25 | Mis, N, F, S | 7508, ENSG00000154767, XP3, XPC, XPCC |
| XPO1 | exportin 1 (CRM1 homolog, yeast) | 7514 | 2 | 2p15 | Mis | 7514, CCDS33205.1, CRM1, DKFZp686B1823, ENSG00000082898, O14980, XPO1 |
| YWHAE | tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, epsilon polypeptide (14-3-3 epsilon) | 7531 | 17 | 17p13.3 | T | 14-3-3 epsilon, 14-3-3E, 7531, CCDS11001.1, ENSG00000108953, FLJ45465, KCIP-1, MDCR, MDS, P62258, Q4VJB6, Q53XZ5, YWHAE |
| ZNF145 | zinc finger protein 145 (PLZF) | 7704 | 11 | 11q23.1 | T | 7704, CCDS8367.1, ENSG00000109906, PLZF, Q05516, Q59H43, Q71UL5, Q71UL6, Q71UL7, ZBTB16, ZNF145 |
| ZNF198 | zinc finger protein 198 | 7750 | 13 | 13q11-q12 | T | 7750, ENSG00000121741, FIM, MYM, Q5W0Q3, Q9UBW7, RAMP, ZMYM2, ZNF198 |
| ZNF278 | zinc finger protein 278 (ZSG) | 23598 | 22 | 22q12-q14 | T | 23598, CCDS13896.1, ENSG00000100105, PATZ1, Q9HD72, ZNF278 |
| ZNF331 | zinc finger protein 331 | 55422 | 19 | 19q13.3-q13.4 | T | 55422, CCDS33102.1, ENSG00000130844, Q68D63, Q6PK05, Q71QC3, Q71QC4, Q71QC5, Q71QC6, Q71QC8, Q71QC9, Q8NBU2, Q9NQX6, RITA, ZNF331, ZNF361, ZNF463 |
| ZNF384 | zinc finger protein 384 (CIZ/NMP4) | 171017 | 12 | 12p13 | T | 171017, CCDS8557.1, ENSG00000126746, ZNF384 |
| ZNF521 | zinc finger protein 521 | 25925 | 18 | 18q11.2 | T | 25925, CCDS32806.1, DKFZp564D0764, EHZF, ENSG00000198795, Evi3, MGC142182, MGC142208, Q8IXI0, Q8IYZ2, Q8TES6, Q96K83, Q9C065, Q9HAL5, Q9UFK4, ZNF521 |
| ZNF9 | zinc finger protein 9 (a cellular retroviral nucleic acid binding protein) | 7555 | 3 | 3q21 | T | 7555, CCDS3056.1, CNBP, DM2, ENSG00000169714, P62633, Q4JGY0, Q4JGY1, Q5U0E9, Q6T598, RNF163, ZNF9 |
| ZRSR2 | zinc finger (CCCH type), RNA-binding motif and serine/arginine rich 2 | 8233 | X | Xp22.1 | F, S, Mis | 8233, ENSG00000169249, MGC142014, MGC142040, U2AF1-RS2, U2AF1L2, U2AF1RS2, URP, ZRSR2 |
A, amplification; AEL, acute eosinophilic leukemia; AL, acute leukemia; ALCL, anaplastic large-cell lymphoma; ALL, acute lymphocytic leukemia; AML, acute myelogenous leukemia; AML*, acute myelogenous leukemia (primarily treatment associated); APL, acute promyelocytic leukemia; B-ALL, B-cell acute lymphocytic leukaemia; B-CLL, B-cell Lymphocytic leukemia; B-NHL, B-cell Non-Hodgkin Lymphoma; CLL, chronic lymphatic leukemia; CML, chronic myeloid leukemia; CMML, chronic myelomonocytic leukemia; CNS, central nervous system; D, large deletion; DFSP, dermatofibrosarcoma protuberans; DLBL, diffuse large B-cell lymphoma; DLCL, diffuse large-cell lymphoma; Dom, dominant; E, epithelial; F, frameshift; GIST, gastrointestinal stromal tumour; JMML, juvenile myelomonocytic leukemia; L, leukaemia/lymphoma; M, mesenchymal; MALT, mucosa-associated lymphoid tissue lymphoma; MDS, myelodysplastic syndrome; Mis, Missense; MLCLS, mediastinal large cell lymphoma with sclerosis; MM, multiple myeloma; MPD, Myeloproliferative disorder; N, nonsense; NHL, non-Hodgkin lymphoma; NK/T, natural killer T cell; NSCLC, non small cell lung cancer; O, other; PMBL, primary mediastinal B-cell lymphoma; pre-B All, pre-B-cell acute lymphoblastic leukaemia; Rec, recesive; S, splice site; T, translocation; T-ALL, T-cell acute lymphoblastic leukemia; T-CLL, T-cell chronic lymphocytic leukaemia; TGCT, testicular germ cell tumour; T-PLL, T cell prolymphocytic leukaemia;



